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Atomic force microscopy (AFM) is a particularly useful tool for obtaining structural 
information about drug-nucleic acid interactions. The mode of drug binding— 
intercalation versus groove binding— can be determined from images acquired on 
individual DNA molecules as the length of a DNA molecule increases in direct 
proportion to the number of intercalators bound to it.  
 
The efforts of this research were directed toward elucidating the mode of binding of a 
series of drugs based on multimers of naphthalenetetracarboxyl diimide (NDI) interacting 
with a linearized DNA plasmid. During the course of the investigation, DNA 
intercalation was confirmed as the mode of binding and the binding affinity estimated. 
Unexpectedly, concentration-dependent formation of secondary DNA structures 
including condensates was observed. DNA toroids, spheres, and rods were imaged and 
measured. Conformations that are believed to be intermediate condensate forms were also 
identified at lower poly-NDI concentrations.  Models for the DNA condensation process 
have been proposed. 
 
Ultimately, this research furthers the understanding of DNA condensation which can be 
applied to gene delivery systems and anti-viral agents. It may also help direct the 




ATOMIC FORCE MICROSCOPY 
 
The following chapter was written as a general overview of Atomic Force Microscopy 
and will be published in the Encyclopedia of Analytical Chemistry (Elsevier, in press).  
 
History and Background 
Scanning Probe Microscopy (SPM) is a family of related techniques that provide 
information about atomic scale structure and processes.  The first of these to be 
developed was Scanning Tunneling Microscopy (STM) by Gerd Binning and Heinrich 
Rohrer at IBM Zurich in 1981 [1].  They were awarded the Nobel Prize in Physics in 
1986 for their invention. Atomic Force Microscopy (AFM) is another SPM technique 
invented by Gerd Binning, Calvin Quate, and Christopher Gerber in 1986 to expand the 
types of surfaces on which atomic scale information can be obtained [2].  Digital 
Instruments (Santa Barbara, California, USA) produced the first commercial AFM in 
1989.  
 
These powerful techniques and others have been rapidly adopted by the scientific 
community and applied in numerous fields ranging from biology to materials science.  
The number of publications and patents has increased exponentially over the last twenty 
years (Figure 1.1).  SPM accounted for 8% of the microscopy market in 2002 worth $US 














































Figure 1.1 Publications in the field of Atomic Force Microscopy from its invention 




The largest producer of SPM instruments is Veeco Instruments, Inc. (Santa Barbara, 
California, US), which acquired several AFM producers including Digital Instruments, 
Topometrix and Park Scientific Instruments.  Asylum Research, Pacific Nanotechnology,  
 JEOL, Omicron NanoTechnology and Nanonics Imaging are other major manufacturers 
(Table 1.1).  
 
AFM Capabilities 
AFM can achieve atomic resolution under certain conditions; however, surface features 
are typically resolved on the nanometer scale laterally and the angstrom scale vertically 
[3]. This resolution is comparable to that of transmission electron microscopy (TEM). 
Resolution of AFM depends on tip shape, scan domain, and number of measurements per 
scan. Unlike many other forms of microscopy, AFM does not require any stains, contrast 
agents, or conductive coatings that can cause partial obstruction of the actual sample.  In 
addition, AFM sample preparation is fairly simple and quick.  AFM is a nondestructive 
method that allows the sample to be reused for additional analyses over time.  
 
AFM has advantages over other techniques such as Nuclear Magnetic Resonance (NMR), 
X-ray crystallography, and Scanning Tunneling Microscopy (STM).  These other 
techniques lack AFM’s ability to image a variety of materials (i.e., nonconductive, 
magnetic, biological) under a variety of environmental conditions (i.e., ambient air, 
various gases, different humidity levels and temperatures). AFM provides the ability to  
 4
 
Table 1.1 Scanning Probe Microscope instrument and cantilever manufacturers 
 
Manufacturer Name Headquarters Location Website 










Moscow, Russia www.mtu-net.ru/nanoscan 
JEOL Europe Ltd.  / JEOL 
USA, Inc. 
Japan www.jeol.com 
JPK Instruments AG Berlin, Germany www.jpk.com 
Klocke Nanotechnik Aachen, Germany www.nanomoter.de 
Molecular Imaging Tempe, Arizona, USA www.molec.com 
MikroMasch Tallinn, Estonia www.spmtips.com 
Nanofactory Instruments Goteborg, Sweden www.nanofactory.com 
Nanonics Imaging Ltd. Jerusalem, Israel www.nanonics.co.il 
Nanosurf AG Basel, Switzerland www.nanosurf.com 
Novascan Technologies Ames, Iowa, USA www.novascan.com 







Santa Clara, California, 
USA 
www.pacificnanotech.com 
PSIA Sungnam, Korea www.advancedspm.com 
Quesant Instruments Corp. Agoura Hills, California, 
USA 
www.quesant.com 
RHK Technology, Inc. Troy, Michigan, USA www.rhk-tech.com 
Surface Imaging Systems 
GmbH 
Herzogenrath, Germany www.sis-gmbh.com 
Triple-O Microscopy 
GmbH 
Potsdam, Germany www.triple-o.de 
Veeco Instruments, Inc. Woodbury, New York, 
USA 
www.veeco.com 










AFM measures the surface topography of a sample on a nanometer scale and the 
attractive and repulsive forces on a picoNewton scale [3].  An analogy can be made 
between AFM and a blind person using a cane to navigate along a landscape. The blind 
person strokes or taps their cane along the ground to feel where the ground is higher or 
lower, as well as softer or harder and rougher or smoother.  In the same way, AFM is able 
to feel the surface topography and force characteristics of the sample.  Figure 1.2 shows a 
general scheme of the key components of an AFM. AFM works by scanning a sample 
under an extremely sharp tip (ideally atomically sharp) integrated on the end of a 
cantilever.  The cantilever bends up or down as it contacts features on the surface.  The 
most common method to measure these small movements uses a laser beam focused on 
the end of the cantilever that is reflected onto a position sensitive detector [4].  Changes 
in the angle of the cantilever, induced by changes in sample topography, result in 
different voltage levels out of the detector.  These voltages are sent to a computer for 
processing and display of the topographic image.  The user can enter control parameters 
such as the scan size (the range that the probe tip will travel across the sample), scan rate 
of the tip above the surface, and feedback control (to maintain a constant height between 
the tip and substrate) into the computer interface. The commands from the user interface 
are then sent to a control module that converts these commands (such as a metric scan 



















holds the sample rigidly in place. Rigidity needs to be emphasized because AFM requires 
minimization of all sources of electrical and mechanical noise [5]. Typically, electrical 
wires in the microscope are fully shielded and all mechanical fixtures are held tightly in 
place. The entire microscope is mounted on an anti-vibration apparatus. These can range 
from simple homemade anti-vibration units such as a concrete block hanging from 
bungee-cords (~$100) to anti-vibration tables that have pneumatically suspended 
tabletops (> $2,500). If these types of noise are not controlled or reduced, visualizing 
atomic-scale features is impossible. 
 
The AFM instrument system described above and shown in Figure 1.2 is the simplest and 
most commonly used in commercial instruments. Variations of this scheme include 
scanning the tip over the sample surface to allow analysis of larger samples and the use of 
different detectors to allow analysis of rougher samples [6].  
 
Cantilevers 
Cantilevers are commercially produced from silicon and silicon nitride using 
microfabrication processes similar to those employed in integrated circuit manufacture 
[7]. Cantilevers are often coated with metal on the top side to enhance laser reflection. 
There are two primary geometries of AFM cantilevers- triangular and rectangular (Figure 
1.3a and b).  Rectangular cantilevers are susceptible to torsional bending during contact 
mode imaging whereas, triangular cantilevers have been designed to reduce the lateral 





Figure 1.3 Atomic force microscopy cantilevers imaged by electron microscopy;  
a) Triangular cantilevers (Courtesy of Veeco Instruments, Inc.),  
b) Rectangular cantilever (Courtesy of MikroMasch), c) Hi’Res cantilever 





The fundamental resonant frequency of the cantilever should be high in order to avoid 
interference from building vibrations and acoustic noise [8]. Thermal noise from the 
cantilever can limit the sensitivity of the AFM and should be minimized by using shorter 
length cantilevers. A shorter length cantilever also provides greater angular displacement 
of the laser resulting in greater resolution.  The spring constant (k) of a rectangular 
cantilever is calculated from its geometry (w = width, l = length, and t = thickness) and 
material properties (Young’s modulus, E) [5]. The equation for the spring constant of a 





Ewtk =  
Equation 1.1
The spring constant increases with cantilever width and thickness but decreases with 
cantilever length. Typically stiffer cantilevers are used for dynamic imaging modes [8].  
 
The geometry of the cantilever tip is critical to the quality of the AFM image and for 
achieving nanoscale images [7]. The overall tip geometry is often square pyramidal 
resulting from an etching process. The aspect ratio (height to width ratio) of the tip is 
important for imaging rough samples in order to fully contact recesses. The tip sharpness, 
or the radius of curvature at the apex, will produce artifacts in the final image. Care must 
be taken to minimize the possibility of creating a double-tip where multiple points of the 
probe interact with the sample. This can lead to tip-induced artifacts in the topographical 
image (Figure 1.4). Recently, carbon nanotubes have become popular tips because of 
their high aspect ratio, small radius of curvature, and durability (Figure 1.3c) [9]. Tips are 
often functionalized in order to study tip to sample interactions or to conduct chemically 









Figure 1.4 AFM image of pBluescript II’ plasmid DNA demonstrating double image 
due to tip contamination 
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Arrays of parallel cantilevers have been developed for use in sensor applications, data 
storage, and increasing scan sizes and imaging speed [6].  
 
Piezoelectric Scanner 
Piezoelectrics are materials whose crystal structure undergoes a physical change due to 
an applied electric field.  If the voltages that are applied to a piezoelectric are precisely 
controlled, extremely precise movements can be performed. The geometries of the 
piezoelectric devices used in AFM are bars, bimorphs or tubes; the most commonly used 
are tubular [11]. These devices operate at a high resonant frequency, enabling high scan 
rates. Thermal isolation of the piezoelectric elements is necessary since these ceramics 
are also sensitive to temperature fluctuation. The sensitivity of a piezoelectric to 







∆ α  
Equation 1.2
where x0 is the original dimension of the piezoelectric, ∆α  is the difference between 
thermal expansion coefficients of the different materials and ∆T is the temperature 
variation [11]. Piezoelectric scanners exhibit both linear and nonlinear responses to an 
applied voltage. As a result, careful scanner calibration is required. Scanner dimensions 
must be carefully matched with the desired image domain.  
 
Typically there are two types of scanner placement: 1) a sample is mounted directly to 
the piezoelectric scanner and rastered underneath the cantilever, 2) the cantilever is 
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mounted to a scanner tube and rastered over a sample fixed below it [4]. The latter case is 
advantageous in imaging larger samples and increases the speed of imaging. 
 
Alternatively, the cantilever can be scanned over the sample in the x and y directions and 
controlled in the z direction using an integrated piezoelectric actuator on the cantilever.  
This is done by coating the cantilever with a thin film of zinc oxide which a voltage is 
applied across to yield bending [12].  This system is advantageous in imaging larger 
samples and increasing the speed of imaging. 
 
The scanner design results in bowing of the image due to the bending motion of the 
scanner cylinder. This results in the tip moving out of the plane of the sample and the 
feedback loop causes the scanner to contract in an attempt to maintain a constant 
deflection [11]. The effect is more predominant in large scan sizes. This artifact is 
customarily removed from the image using graphics software to mathematically “flatten” 
the images. 
 
It is imperative that movements of the scanner be frequently calibrated against a certified 
standard. This will allow users to compare results from one instrument to the next and, 
more importantly, instills confidence in the length scales of the measured topographical 
features. The user must remain cognizant that they cannot visually see the sample. The 
image displayed is a pictorial representation of the changes in cantilever deflection as a 
function of movement in the scanner.  If movement of the scanner is poorly calibrated 




The original AFM used an STM to sense the movement of the cantilever in response to 
interactions with the sample [1].  Optical detectors in most commercial AFM have 
supplanted this type of electrical detector [4].  The most widely used detection system 
uses a laser beam reflected off the end of the cantilever onto a position sensitive detector. 
A change in the angle of the cantilever moves the spot on the detector, producing a 
change in the voltage sent from the detector and used to generate the topological map.   
 
Interferometry is another detection system where a laser beam is reflected off the end of 
the cantilever [13]. The phase change of the reflected laser beam is then compared to that 
of a standard to determine the change in cantilever position. This type of detection offers 
a better signal to noise ratio but it is more difficult to set up and requires better 
vibrational and acoustic isolation.   
 
Integration of the detector into the cantilever has also been accomplished using the 
piezoresistive properties of silica [14].  This is beneficial for samples that are light 
sensitive and following the movements of cantilevers in an array.  It can be used in 
conjunction with the integrated piezoelectric actuator; however, it can be difficult to 
decouple the signals. 
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AFM Operational Modes 
Atomic Force Microscopy can be operated in several modes to optimize topographical 
imaging of different types of samples, to explore different surface properties of samples, 
or to modify the surface [5, 11, 15]. 
 
Contact Mode 
Contact mode is the simplest form of AFM.  The cantilever tip is brought into intimate 
contact with the sample surface where the force exerted on the tip is constantly 
maintained.  The difference between the actual force and a predefined setpoint force is 
corrected via a closed-loop feedback system.   
 
Proportional and integral gains of the instrument can be set by the user to adjust the 
performance of the feedback system [3].  The proportional gain is multiplied by the 
difference between the actual force and the setpoint.  The integral gain is the time weight 
that is integrated over the difference between the actual force and the setpoint.  If the 
gains are too high, feedback oscillations may excite the resonance frequency of the 
scanner. If the gains are too low, resolution is poor due to slow reaction of the feedback 
loop .  
 
When operating in the constant force mode, the force between the tip and the sample are 
kept constant. As the tip travels over high or low areas, the changes in the scanner 
movement in the z-direction are plotted as a function of the x and y position of the 














constant separation distance between the tip and sample. This is accomplished via the 
integration of a feedback loop between the scanner and the controller. Thus, the position 
of the tip is being monitored and if, for example, the tip force gets too high during 
constant force mode, the controller will increase the separation between the tip and the 
substrate to maintain the set force level. 
 
Force curves are used to interpret the interaction of the cantilever tip as it comes into 
contact with the sample [16]. Typical force curves with tapping mode and contact mode 
are depicted in Figure 1.6. Force curves are obtained by disabling the scanner movement 
in the x and y directions and oscillating the scanner in the z-direction. As the tip 
approaches the sample, initially no cantilever bending is exhibited. Once the cantilever 
tip is extremely close to the sample, the cantilever will be pulled down due to the van der 
Waals interactions between the tip and the substrate. This jump to contact can also be 
induced by the presence of a thin hydration layer on the surface. After the tip is in contact 
with the sample, the sample continues to move upward, which bends the cantilever up.  
When the sample is then retracted from the tip, the cantilever straightens.  However, 
instead of being released from the surface at the same point as it came in contact, the tip 
may be held on the surface by the attractive or adhesive forces thus causing the cantilever 
to bend down.  Finally, when the restoring force of the cantilever exceeds the attractive or 





Figure 1.6 AFM force curves tracking the position of the cantilever as the 
piezoelectric scanner cycles up and down: a) typical tapping mode force 
curve with limited attractive forces between tip and sample, and b) force 
curve for highly hydrated sample or contaminated tip demonstrating 
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Friction Force Imaging 
Friction force mode is an extension of contact mode to measure the local variations of 
adhesion that may exist between the cantilever tip and the substrate [17].  Lateral forces 
on the tip cause torsional bending of the cantilever that is detected by horizontal 
movement of the laser spot on the detector. 
 
Force Modulation Imaging 
A relatively new contact mode technique is force modulation imaging [18]. This scanning 
probe method elucidates both topological and the corresponding elastic properties of a 
substrate. Force modulation involves placing a bimorph (or piezoelectric) actuator in 
contact with a cantilever chip. The actuator is then driven at its resonant frequency and 
when this cantilever/actuator is brought into contact with the sample, the cantilever tip 
indents the sample. Areas that are more difficult to indent will require that a higher 
driving voltage be applied to the actuator (representative of a stiff surface) or a very low 
driving voltage may need to be applied to indent a pliant area of the substrate. This 
technique has been integral in characterizing the mechanical and topological properties of 
composite materials.       
Noncontact Mode 
Noncontact or Dynamic Force mode focuses on longer-range molecular forces [19].  The 
cantilever is driven to oscillate at its resonance frequency by a piezoactuator.  The surface 
topography is measured by the shift in cantilever frequency based on tip/sample 
interactions.   
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Intermittent Contact Mode 
Intermittent contact mode was developed by Zhong et al. at Bell Labs in 1993 [20].  
Intermittent contact or TappingMode™ is similar to noncontact mode in that the 
cantilever is driven to oscillate at its resonance frequency [21].  However, the change in 
oscillation amplitude is used as the control parameter, in comparison to the change in 
oscillation frequency in noncontact mode. The root mean square (RMS) value of the 
detector deflection is used to control the tip/sample distance via the feedback loop.  
 
The major advantage of the intermittent contact mode is that lateral forces are greatly 
reduced [22].  This facilitates its use with soft molecules or molecules that are not 
strongly attached to the surface.  A low drive amplitude and low RMS force are desired 
to minimize impact on soft molecules; however they must be sufficient to overcome 
attractive capillary forces.  This problem can be resolved by imaging under fluid.  
Imaging under fluid also provides the opportunity to examine interactions between the 
substrate and molecules in the liquid environment. 
Phase Imaging 
Phase imaging is an extension of intermittent contact mode to measure surface properties 
such as adhesion, friction, and elasticity [23].  Phase imaging detects the phase shift of 
the cantilever oscillation, which is related to the surface rigidity.  Phase shifts above 90 





Atomic force microscopy has been applied to similar fields as STM; however AFM 
enables scientists to visualize nonconducting surfaces that were not possible with STM. 
This analytical tool has elucidated and coupled mechanical properties with surface 
morphology.  Biological researchers have utilized AFM for studying DNA interactions,   
protein conformations, enzyme reactions, and cell membrane structures [24-27]. Material 
scientists have used AFM to study surface properties of polymers, plastics and coatings 
[6, 28-30].   
 
The AFM has more recently found an application aside from surface characterization. It 
has been used to test the mechanical properties of a myriad of biological molecules and 
polymers (single molecule mechanical testing) [31, 32]. The AFM has also been used to 
measure nano-scale adhesion that may exist between a chemically modified cantilever 
and a substrate (typically called chemical force microscopy) [10, 33]. The experimental 
design for the single molecule mechanical testing is an elegant example of the chemist’s 
ability to chemically tailor surfaces on the nano-scale. Generally these experiments are 
done by tethering a molecule on either a substrate or the end of the cantilever tip via 
coupling chemistry. The free end of the molecule possesses a reactive group that couples 
with the opposing surface. The cantilever tip is brought into close proximity with the 
substrate, leading to the coupling of the free end of the molecule and the surface bound 
reactive group. The substrate is then pulled away from the cantilever, leading to the 
mechanical unfolding of the anchored molecule. These experiments are interpreted by 
closely analyzing the force curves that are generated during the pulling process. Figure 
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1.7 represents the tensile loading of an elastin-mimetic peptide molecule that is 
repetitively pulled.  
  
AFM has been employed in manufacturing and quality control of microelectronics, 
including semiconductor silicon wafers, MEMS devices, CDs/DVDs and computer hard 
disks [34-36].  Often the defects are smaller than the wavelength of light making optical 
analysis ineffective.  
 
An evolving area of AFM application is nanomanipulation in which the AFM tip 
modifies the sample surface at an extremely small scale. This can be achieved by 
frictional wear, controlled surface oxidation, and/or deliberate material transport between 
two surfaces. With the latter, molecules or cells can be attached to the AFM tip and 
transferred to the opposing surface at specific locations. Alternatively, thermal patterning 
of substrates can be achieved by contacting a heated cantilever tip with the surface. 
Potential applications include preparation of ultra-high density data storage devices and 
molecular machines.  
 
In summary, scanning probe microscopy has revolutionized the understanding of 












Figure 1.7 Sequential force curves acquired with the AFM that were obtained during 




DNA INTERCALATION AND CONDENSATION 
 
DNA 
Deoxyribonucleic acid (DNA) is the “polymer of life”. DNA is composed of units of 
purine and pyrimidine bases attached to a backbone of a 5-carbon sugar (dexoyribose) 
alternating with a phosphate group. The purine bases— adenine (A) and guanine (G), and 
pyrimidine bases—  thymine (T) and cytosine (C) are paired together A to T and G to C 
to allow replication of the DNA code (Figure 2.1a). The bases are made up of nitrogen 
and carbon atoms arranged in planar ring structures (Figure 2.1b). DNA is typically 
double stranded in a “spiral staircase” structure with the paired bases forming the “steps” 
(Figure 2.2).  
 
DNA can be found in three principal forms: A, B, and Z (Figure 2.3) [37]. The A form 
occurs under anhydrous conditions (<75% relative humidity) and is found in bacterial 
spores. The A form has 11 basepairs per helical turn, a helical rise per basepair of 0.26 
nm, and a diameter of 2.6 nm.  The B form is the most common form found under natural 
conditions. It has 10 basepairs per helical turn, a helical rise per basepair of 0.34 nm, and 
a diameter of 2.0 nm. Both the A and B forms are right-handed helices, however, the Z 
form is a left handed helix and is believed to serve as a genetic switch. The Z form has 12 





Figure 2.1 Structural representations of deoxyribonucleic acid (DNA) a) backbone 
and basepairs, b) chemical structures of purine and pyrimidine bases: (A) 










Figure 2.2 Depiction of double stranded DNA as a spiral staircase with phosphate 
and sugar backbones represented by orange banisters and basepairs 













Figure 2.3 Structural models of the three forms of DNA  
A form Z form B form 
Source: www.lmb.uni-muenchen.de/groups/Biostruc/chap-08/chap-08-slides.html
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A major and minor groove traversing the spiral structure are formed by the DNA 
backbone (Figure 2.4a). The major and minor grooves differ not only in size, but also in 
polarity and chemistry [40]. The chemistries present in the grooves are specific to the 
basepairs which can lead to sequence specific binding in the grooves. In the major groove 
A-T has a sequence of acceptor-donor-acceptor and G-C has a sequence of acceptor-
acceptor-donor (Figure 2.4b). The major groove has more binding sites and exhibits 
directionality (e.g. AT vs. TA). 
 
DNA is a polyanion which attracts positively-charged counterions such as calcium and 
magnesium ions in buffer solutions to shield the electrostatic charges. DNA is a fairly 
stiff molecule with a persistence length of about 50 nm. According to the IUPAC 
Compendium of Macromolecular Nomenclature, persistence length is “the average 
projection of the end-to-end vector on the tangent to the chain contour at a chain end in 
the limit of infinite chain length” [41]. DNA can be treated mathematically using the 
worm-like chain (WLC) model [42]. 
 
DNA serves two central roles. First, it maintains the genetic information and is replicated 
to pass this information to each new cell. Second, it contains the code which is translated 
into RNA which is then transcribed into proteins (Figure 2.5). This has become known as 




Figure 2.4 Major and minor grooves formed by DNA helix– a) relative groove size 
illustrated with space-filling model, b) chemical structure of basepairs 





Major groove Major groove 
Minor groove Minor groove 







Figure 2.5  The “Central Dogma of Molecular Biology” depicting the key cellular 
processes of DNA replication and translation (Access Excellence at 






DNA and Drug Interactions 
Anti-cancer therapies often target the DNA to inhibit the rapid replication of cancer cells. 
Many diseases such as diabetes, Lupus, hemophilia, Huntington's disease, and 
Alzheimer's disease may be traced to over- or under-production of proteins or production 
of mutated proteins. DNA is the genetic material that codes for proteins; therefore, drug 
interactions with DNA which can affect this process are potential treatments for these 
types of diseases. The mode of action of some drugs for the treatment of cancer, genetic 
disorders, and viral diseases is thought to be based on their binding to DNA and their 
modification of DNA activity. The activity of the drug is often linked to the binding 
geometry. Thus, the potential activity of a drug could be assessed by detecting the DNA 
binding location and fit of the drug candidate. An analytical technique to elucidate the 
mode of DNA/drug interaction could be important for the design of advanced drugs. 
 
Analytical Techniques 
Currently, drug developers assess the interactions of drugs with DNA through indirect 
assays, computer modeling, and clinical trials. These methods do not provide the insight 
required to rationally design or screen the compounds. Most clinical drug design and 
screening methods deduce the effects of compounds based upon the biological products 
produced downstream in the process, such as amino acids and proteins. AFM is the only 
method of directly observing interactions of compounds with individual DNA molecules 
without stains and under natural conditions with simple sample preparation.  X-ray 
crystallography, Nuclear Magnetic Resonance (NMR), absorption spectroscopy, gel 
electrophoresis, and Scanning Electron Microscopy (SEM) are some of the other 
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analytical techniques that have been used in attempts to investigate drug interactions with 
DNA and the resulting DNA conformations; each has distinct advantages and 
disadvantages.  
 
X-ray crystallography records and analyzes the diffraction pattern of x-rays focused on a 
highly ordered crystal to determine the molecular structures of the substance that 
comprises the crystal. This method is highly sensitive to extremely small changes in 
structure and the position of atoms and molecules in relation to one another. It requires 
that the material can be highly concentrated into a nearly defect free, highly ordered 
crystal form. The molecular conformation in the crystal may be significantly different 
from the conformation in solution. The preparation of the pure crystal sample is 
challenging and requires hours, days, or weeks of effort. The information about bound 
compounds is gathered statistically from the numerous molecules in the sample, but is 
highly accurate. 
 
Nuclear Magnetic Resonance (NMR) spectroscopy uses radiation to induce nuclear spin 
state changes which are unique for different atoms and their local environment. From the 
spectrum acquired on solid or liquid samples, the structure of molecules can be deduced. 
NMR can observe static as well as dynamic interactions between molecules. It requires 
that the sample be dissolved in a deuterated solvent and averages the results from all the 
molecules in the sample.  The spectrum requires significant expertise to interpret and, 
depending on their complexity, may not be definitive. 
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Circular dichroism (CD) spectroscopy and UV-vis spectroscopy provide structural 
information on molecules based on their absorption of different wavelengths of light. CD 
spectroscopy measures the absorption of left and right handed circularly-polarized light 
which differentiates based on the molecules chirality and secondary structure. UV-vis 
spectroscopy uses the wavelengths of light in the spectrum ranges of 120 to 800 nm. 
DNA typically absorbs in the region of 160 to 300 nm due to the electronic transitions 
regions of the bases. These techniques are conducted in solution and are simple to 
conduct, but average the results across molecules in different states. 
 
Gel electrophoresis separates molecules into bands relating to their characteristics (e.g. 
length, conformation, charge) which can be compared to standards to draw conclusions 
about the sample. It also is fairly quick and easy to conduct, but has the same 
disadvantages of averaging the results of numerous molecules in a sample instead of 
looking at interactions with an individual molecule and requiring interpretation of the 
interactions from indirect evidence. 
 
Electron microscopy can directly image individual molecules; however, stains or contrast 
agents are required which reduce resolution. Electron microscopy is typically done under 
vacuum; molecular conformation in vacuo often differ from those found in natural 
environments. 
 
Atomic Force Microscopy (AFM) can directly image individual molecules without stains 
in liquid, gaseous, or vacuum environments. It can measure the three-dimensional surface 
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profile, as opposed to just providing a two-dimensional image. The main disadvantages 
of AFM are its limited image size, inability to detect chemical bonds, and requirement 
that sample molecules are securely immobilized on a solid surface. 
 
Optical tweezers force spectroscopy, a method related to AFM, has recently been 
employed to study the effect of drug binding on DNA lengthening and elasticity and 
related these properties to the mode of drug binding [44]. 
 
Binding Modes 
Most drug binding to DNA does not involve covalent bond formation and, therefore, is an 
equilibrium process. The binding constant can be determined by measuring the free and 
bound forms of the drug. The thermodynamics are classically driven by electrostatic 
attractions, hydrophobic interactions, hydrogen bonding, and van de Waals forces [45]. 
 
There are two key modes of noncovalent drug interactions with the DNA helix—groove 
binding and intercalation (Figure 2.6), as well as combinations of these modes and non-
specific binding. Polyamines, such as spermidine and spermine, are considered to be non-
specific binders with primary interactions being electrostatic binding to the anionic 
phosphate backbone (Figure 2.7). Cyanine dyes are known to exhibit a combination of 











Figure 2.6  Models of drug and DNA interactions— a) intercalation, b) major groove 
binding, and c) minor groove binding 
 
 




Figure 2.7 Structural models of spermine binding to the phosphate backbone of DNA 
at two different viewing angles based on X-ray diffraction at 1.9 Å 




Figure 2.8 Structural model of dystamycin binding to the minor groove of DNA 
based on X-ray diffraction at 1.85 Å resolution (pdb 1JTL) [39, 48] 
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Groove Binders 
Minor groove binding drugs are typically thin and crescent shaped to sterically fit into the 
narrow minor groove. Examples of minor groove binding ligands include distamycin, 
netropsin, Hoechst 33258, and chromomycin (Figure 2.8). They do not change the gross 
structure of DNA; however, x-ray crystallography has shown that netropsin caused small  
distortions in widening the groove and causing a slight bend in the double helix [49]. 
Studies have also detected that monovalent cations bind in the minor groove and produce 
bending [50].  
 
There are fewer major groove binding drugs, although this is a very common binding 
mode for proteins to regulate gene expression. Examples of major groove binding drugs 
include cisplatin, alkylators, and mustards (Figure 2.9). 
 
Intercalators 
Intercalation occurs when a planar aromatic structure is inserted between the Watson-
Crick basepairs which causes the DNA basepairs to separate and the overall strand to 
lengthen and slightly unwind. Compounds with two or three fused rings do not 
completely fill the space between the basepairs while four fused rings correspond in size 
to stack efficiently with the basepairs [51]. Intercalators generally have a preferential 
binding between 5’ pyrimidine-purine 3’ steps [52]. Examples of intercalators include 
ethidium, daunomycin, echinomycin, actinomycin, and quinacrine (Figure 2.10a). 
Intercalators are effective drugs based on interruption of DNA replication, transcription, 






Figure 2.9 Structural model of phenazine binding to the major groove of DNA based 







Figure 2.10 Structural models of DNA with a) daunomycin mono-intercalation based 
on X-ray diffraction at 1.50 Å resolution (pdb 1DA0) [39, 54] and, b) 
thiazole orange dimer bis-intercalation based on 40 NMR structures (pdb 






Poly-intercalators are a class of intercalators in which multiple intercalating units are 
joined together with a linker compound. The chemical moieties, physical length, and 
rotational rigidity of linker compound have an important influence on the binding affinity 
and selectivity of the intercalator [52, 56]. It has been shown that regional charge 
densities impact the stacking stability and structure [57]. In addition, distortion of the 
DNA occurs with some bis-intercalators the degree of which is dependent on the linker 
structure [58]. Ditercalinium, thiazole orange dimer (TOTO), ethidum acridine, and flexi-
di are examples of bis-intercalators (Figure 2.10b) that have been shown to cause twice 
the DNA helical extension and unwinding of a mono-intercalator.  
 
Traditionally, the detection of intercalation has been based on a spectrophotometric shift 
which requires that the intercalating moieties are chromophores. Another indirect method 
of inferring intercalation has been based on the increase in DNA double helix stability 
resulting in decreased heat denaturation. DNA intercalation can be definitively 
determined based on strand lengthening which is best measured by AFM [59]. Gel 
electrophoresis and viscometry studies rely on DNA lengthening to deduce intercalation, 
but can be complicated by other factors. NMR images of ligands intercalated with DNA 
have been acquired which help establish the structural position of the ligand binding. 
 
Clinical Applications 
Drugs that interact with DNA have clinical significance especially for the treatment of 
solid tumors, lymphoma, and leukemia. The interruption of DNA replication is effective 
against rapidly reproducing cancer cells. More efficient and targeted DNA-binding drugs  
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Table 2.1 List of DNA-interactive drugs used clinically or in clinical research trials 
(key ref.: http://gucfm.georgetown.edu/welchjj/netscut/heme_onc/dnadruglist.html) 
 
Drug Name Chemical Name Mode of Interaction 
Actinomycin D  Intercalation 
Adolzelesin, 
U-73,975 















Cyclopropylpyrroloindole Minor groove 
CC-1065, U-56314 Cyclopropylpyrrolo-indole Minor groove 
Chromomycin A3 Aureloic acid Minor groove 
CI-958, Parke-Davis Benzo(chalcogeno)[4,3,2-cd]indazole Intercalation 
Daunomycin, 
Cerubidine 
 Intercalation, directed 




























Mitomycin C  Minor/Major groove 
Netropsin, T-1384  Minor groove 







Tomamycin Pyrrolo-(1,4)-benzodiazepine Minor groove 
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can be achieved by designing new compounds with multiple binding moieties that bind to 
specific DNA sequences. 
 
Poly-Naphthalenetetracarboxylic Diimide 
A unique series of poly-intercalators has been designed in Brent Iverson’s lab at 
University of Texas, Austin based on aedamer stacking studies. The series is composed 
of 1,4,5,8-naphthalenetetracarboxylic diimide (NDI) aromatic groups linked by four 
amino acid segments (Figure 2.11) [60]. It includes bis-, tris-, and tetra-intercalators with 
enhanced binding affinities and was eventually extended to produce the first octakis-
intercalator [61]. The NDI units were strung together in a head-to-tail fashion with 
variable linker polypeptide sequences. The synthesis of the molecules was accomplished 
using standard 9-fluorenylmethyoxycarbonyl (Fmoc)-based solid-phase methods. A 360- 
member library of different linker sequences was produced using combinatorial methods 
[62]. 
 
Like their aedamer predecessors, the poly-NDI molecules are initially stacked in solution. 
The stacking arrangement is identified by the upfield shift of the diimide hydrogen in 
NMR and the rate-limiting slow unstacking step of the association constant. However, the 
addition of 2% SDS releases the stacking conformation as revealed by the absorption 
spectrum maximum returning to that of the monomer measured by UV-vis spectroscopy 
[60].  
 











Figure 2.11 Structure of 1,4,5,8-Naphthalenetetracarboxylic diimide (NDI) with 











































measurements of some of these compounds are not consistent with this binding mode 
[63]. Threading involves one side chain of the intercalator being located in the major 
groove while the next side chain is located in the minor groove. This geometry requires 
that the intercalator “threads” through the DNA scaffold as shown in Figure 2.12. Other 
intercalators such as anthraquinone [64], poly-NDI derivatives [65], and the related bis-
imide elinafide (LU-79553) [66] were previously demonstrated to exhibit this threading 
geometry. Advantages of the threading mode stem from its obstruction of both DNA 
grooves, improved sequence specificity, and slower dissociation rates. This would have 
implications for drug efficacy to interrupt translation and replication processes. 
 
The specific linker structure of lysine and tri-glycine, has been investigated with UV-vis 
spectroscopy, viscometry, and DNAse footprinting to preliminarily determine that 
intercalation is the binding mode [60]. The compounds were found to have a high binding 
affinity for double stranded DNA, as well as general specificity for GC sequences.  
 
Changing the linker sequences resulted in much stronger sequence specificities allowing 
NMR analysis to resolve DNA binding interactions (Figure 2.13) [67]. Interestingly, the 
reversal of the placement of the lysine after the tri-glycine, instead of before it, yielded 
one of the compounds with greater sequence specificity. In addition, the substitution of 






Figure 2.12 Schematic of threading intercalator with ring moiety (pink) inserted 
between basepairs and linker structures lying in the minor (green) and 










Figure 2.13 NMR structures of bis-NDI compounds with linker structures a) Alanine-
Alanine-Alanine-Lysine in the minor groove, and b) Glycine-Glycine-





DNA condensation is defined as an increase in the volume compression ratio which 
results in the formation of highly-ordered structures. It is differentiated from aggregation 
or precipitation based on the order and finite size of the structures. Condensation occurs 
naturally where replication and transcription are not actively transpiring, such as virus 
capsids and sperm cells [69]. The mechanism of formation of the unique condensate 
morphologies (Figure 2.14) of toroids (doughnut-like structures), spheres, and rods has 
been the focus of much research during the past 30 years, yet it remains elusive.  
 
It is postulated that condensation occurs when 90% of the DNA negative charge from the 
phosphate backbone is neutralized [70]. This electrostatic effect has not been found to be 
sufficient to completely account for the condensation forces. Kinetic and thermodynamic 
based models with electrostatic and hydrostatic mechanisms have been proposed [71].  
Polymer physicists have used a “bead-spring” model of semiflexible polyelectrolytes [72] 
to study this phenomena as a “coil-globule” transition [73, 74], although DNA does not 
truly behave as a random coil to fit the model.  
 
While in vivo condensation is directed by proteins (such as histones), identical structures 
are formed in vitro by a variety of compounds including multivalent cations (Co(NH3)6+3, 
spermidine, and polylysine), ethanol, and PEG. There are obvious energetic barriers 
against the compaction of the DNA molecule to overcome entropy and electrostatic 
repulsions and significant energy is expended by organisms which is estimated to be 
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        Sphere 
 
 
           Rod 
 
Figure 2.14 Classical DNA condensate morphologies of toroid, sphere, and rod 
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that condensation occurs spontaneously in vitro under fairly broad conditions with the 
above listed condensing agents. 
 
Currently, there is much interest in the application of condensation for delivery of DNA 
in gene therapy to afford protection from nucleases and other enzymes during cellular 
entry [76]. The folding of DNA during condensation bears some similarities to protein 




AFM ANALYSIS OF DNA LENGTHENING 
 
Background 
As discussed in Chapter 1, Atomic Force Microscopy (AFM) is well suited for the 
analysis of DNA and drug interactions. AFM is non-destructive and does not require 
stains or coatings that are potentially obstructive or interfere with the interactions under 
observation. AFM has the high resolution necessary for detailed analysis of individual 
DNA molecules. AFM studies with densely packed DNA on a lipid layer under water 
[77] or with extremely sharp tip under propanol [78] have resolved the helical periodicity 
of double stranded DNA. More typically, the resolution is about 10 nanometers primarily 
due to the tip radius of curvature [79]. Humidity has also been shown to affect the 
apparent width of DNA molecules observed with AFM [80]. 
 
As discussed in Chapter 2, the intercalation of DNA results in its lengthening. Coury et al 
established the use of AFM as an accepted assay for intercalation based on its 
measurement of DNA contour lengthening which serves as direct evidence for this mode 
of drug interaction [81]. Bis-intercalation has also been determined using AFM in work 
with thiazole orange dimer by Jeff Petty’s lab [46, 82].   The studies reported herein set 




Most AFM studies of DNA and intercalator binding have shown lengthening of the DNA 
strands without noticeable changes in secondary structure [24, 30]. Recently, Berge, et al. 
[82, 83] have observed complex structural changes in DNA with the bis-intercalators 
ditercalinium and luzopeptin which were attributed to intermolecular crosslinking. 
Similar DNA structures and complete condensates have been observed by AFM with 
increasing concentrations of spermidine and polylysine which are known condensing 
agents [84-86].  
 
AFM Technique 
The research reported herein was performed using a Nanoscope IIIa AFM controller with 
a Multi-Mode base (Veeco, Santa Barbara, CA). The instrument was mounted on a 
vibration isolation table to reduce environmental noise. TappingMode™ intermittent 
contact mode imaging was utilized. This mode has become more popular than contact 
mode because of its lesser force exerted on the soft biomolecules [87]. A Veeco J scanner 
(125 µm x 125 µm scan size, 5.0 µm vertical range) was used which allowed larger areas 
of the sample to be examined, while still permitting highly detailed imaging of small 
features. The scanner was calibrated in the x, y, and z directions using a NIST certified 
grating (Figure 3.1). 
 
Rectangular silicon cantilevers (MikroMasch Model NSC12 B; Tallinn, Estonia) with 
approximate dimensions of w = 35 µm, l = 90 µm, and t = 2 µm were used. The spring 
constant (k), calculated according to the equation given in Chapter 1, is approximately 14 




Figure 3.1 NIST certified silicon grating (MikroMasch TGZ02) used for the 
calibration of the Nanoscope IIIa with J scanner a) AFM topographic 
image with accurate x and y measurements of 3.0 µm, and b) scope trace 




imaging session or whenever the tip became contaminated as was detected by a double or 
multiple trace image (Figure 1.4). The cantilever was tuned to its resonance frequency 
which was between 250 and 400 kHz and used at the minimum drive amplitude between 
10 and 150 mV in order to reduce the pressure exerted by the tip on the molecules during 
imaging. 
 
All studies were conducted under ambient conditions (20% to 50% humidity, 22º to 23º 
C). This simplified the experimental set up and accelerated the rate of research. A few 
experiments were conducted with controlled humidity (22% r.h.), but no noticeable 
differences in the images were discerned. 
 
Scan sizes ranged from 5 µm to 400 nm at a scan rate of 1.5 Hz and 512 x 512 pixels. 
This scan speed was preferred to produce better images with higher confidence in length 
measurements and is commonly recommended for this scan size range [88].  Faster scan 
speeds may be acceptable for length measurements of long DNA molecules given the 
already large standard deviations. Significant efforts are aimed at increasing scan speed 
while maintaining resolution using smaller cantilevers or integrated piezoelectric 
actuators [89]. 
 
AFM data were processed using the Nanoscope software (version 4.22, 5/29/96). Images 
were flattened using the appropriate order to remove background sloping. The contour 
lengths of DNA molecules were determined by manually tracing the strands using the top 
view mode of the software (a tedious and time-consuming process). Several attempts 
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have been made to computerize these measurements [90]. Contour lengths were also 
measured using software developed by Dr. Jeff Petty’s lab (Furman University) run in 
Igor Pro (WaveMetrics, Inc., Lake Oswego, OR). Length measurements by both methods 
were found to be approximately equivalent, however concerns about pixel averaging led 




All experiments reported herein used plasmid pRS316 DNA (4,887 base pairs) provided 
by Dr. Nick Hud’s lab (Georgia Institute of Technology). This plasmid was selected 
based on its length, sequence, and selection of restriction enzyme excision sites. It 
included an ampicillin resistant gene which was useful in expression. The sequence had a 
1:1.2 ratio of GC:AT bases and several significant AT tracts were present (see Appendix 
A for complete sequence).  
 
The plasmid had been maintained in E. coli DH5a bacteria in cryogenic storage in a 50% 
glycerol solution to protect them during freeze/thaw cycles. A small portion of the culture 
was thawed and plated using aseptic procedures. The bacteria were streaked onto a Petri 
dish containing a solid Luria-Bertani base and 100 µg/mL ampicillin (LB+amp) in agar. 
The plate was inverted and incubated at 37º C for 15 hours. In order to reduce colony 
growth, the Petri dish was sealed with Parafilm and stored in an inverted position in the 
refrigerator for several hours. A fresh culture was started by inoculating a single colony 
into 2 mL of LB+amp liquid growth media in a round bottom tube with an air flow cap to 
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provide maximum air exposure for aerobic bacterial growth. The tube was incubated at 
37º C for 5 hours in a shaker at 225 rpm. A large, fast-growing culture was then started 
by inoculating 1 mL of the smaller culture into 250 mL of LB+amp broth in a flask and 
incubating in a similar manner overnight. The plasmid was separated from the bacteria 
and purified using a Quiagen maxi prep kit (Quiagen Sciences, Germantown, MD) 
following the high-copy instructions provided by the manufacturer.  
 
The plasmid was linearized using Sca I restriction endonuclease enzyme (Promega, 
Madison, WI) to produce a blunt cut at a single site. The buffer K provided by Promega 
which was optimized for Sca I activity was diluted from 10x to 1x. This pH 7.4 buffer 
contained 10 mM Tris-HCl, 10 mM MgCl2, and 150 mM KCl.  The concentration of the 
plasmid was estimated based on UV-vis spectroscopy with small volume glass cuvettes 
(Fisher Scientific) and a Shimadzu UV-1601 spectrophotometer. Approximately 10 µg of 
plasmid and 2 µL of the Sca I were added to 28 µL of buffer K. This solution was mixed 
gently and incubated in a water bath at 37º C (enzyme optimal temperature) for 17 hours, 
then stored in the refrigerator for a few hours. 
 
Single cut linearization was confirmed with an agarose gel. A horizontal gel was prepared 
with 0.7% molecular biology grade agarose (International Biotechnologies, Inc, New 
Haven, CT) in Tris Borate EDTA (TBE) buffer containing 0.01% ethidium bromide to 
provide a fluorescent marker. The gel was run using a Kodak BioMax OS710 
electrophoresis apparatus filled with TBE buffer set at 160 volts for 30 minutes until the 
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loading dye bands approached the end of the gel. The gel was placed on a UV lamp table 
to view the fluorescence of the ethidium bromide tagged DNA bands (Figure 3.2). 
 
Final purification of the plasmid was achieved using a Microcon 30 centrifugal filter 
(Millipore Corp., Billerica, MA). The remaining plasmid solution was mixed with 
autoclaved, deionized Milli-Q water to a total of 500 µL and filtered through the 
Microcon 30 filter during centrifugation at 11,000 rpm (~9,880 g force) for 12 minutes in  
an Eppendorf Microcentrifuge 5415C (Brinkmann Instruments Inc., Westbury, NY). The 
fluid was decanted from the bottom of the vial and a fresh aliquot of water was 
centrifuged through the same filter a total of five times to thoroughly rinse the plasmid. 
Then 100 µL of water was pipetted into the top of the filter which was inverted on top of 
a new vial and centrifuged at 3,500 rpm (~1000 g force) for 3 minutes. The fluid was 
returned to the top of the filter and centrifuged a second time to ensure complete removal 
of the purified plasmid. 
 
A stock concentration of 70 µg/mL DNA in filtered (0.2 µm pore, Nalgene, Rochester, 
NY), deionized water (>18 MΩ cm-1, Barnstead E-Pure, Dubuque, IA) was determined 
based on UV-vis spectroscopy absorption at 260 nm (Figure 3.3). Aliquots of the DNA 
were stored in a bio-freezer (-40º C) and thawed to room temperature for use. Dilutions 
were made to achieve final sample concentrations of 1 µg/mL pRS316 DNA. This 
concentration was selected systematically to deliver sample coverage that was not too 
dense causing molecules to cover one another or too dilute making it difficult to find 







Figure 3.2 Horizontal gel electrophoresis UV fluorescence of ethidium bromide-
tagged DNA. Lanes 2 and 3 contain the original, purified circular plasmid 
with two bands representing the open and supercoiled forms, lanes 1 and 4 
contain the linearized plasmid verified by the single band, lane 6 contains 































Figure 3.3 UV-vis spectroscopy absorption curve used to determine DNA 






Bis-, tris- and tetra-1,4,5,8-naphthalenetetracarboxylic diimide (NDI) (Figure 3.4) 
samples were provided by Dr. Brent Iverson’s lab (University of Texas at Austin). They 
had been stored as solids in a bio-freezer for several years. The drugs were yellow 
powders that dissolved fairly easily into filtered, deionized water. Concentrations were 
determined using the Beer-Lambert law based on UV-vis spectroscopy absorption  
measurements and extinction coefficients previously published [60] (Table 3.1). 
Dilutions were made and stock solutions were stored in a bio-freezer and brought to room 
temperature and centrifuged before use. 
 
Buffer 
A 100 mM magnesium chloride and ammonium acetate buffer stock solution was 
adjusted to pH 8.0 using sodium hydroxide. All salts were obtained from Fisher Scientific 
(Hampton, NH) and used as received. The stock solution was stored in a laboratory 
refrigerator. It was brought to room temperature and filtered through a 0.2 µm pore filter 
before dilution to a final sample concentration of 10 mM. The Mg+2 in the buffer 
facilitates electrostatic binding of the negatively-charged DNA onto the positively 
charged mica surface. Other divalent metal cations, such as Ni+2 have been shown to 
efficiently support DNA binding onto mica [91]. Previous studies have established that 












Figure 3.4 Structure and cartoon representation of 1,4,5,8-Naphthalenetetracarboxylic 
diimide (NDI) with peptide linker where a) n =1 for bis-NDI, b) n=2 for 















































+ + + +













Table 3.1 Extinction coefficients of poly-NDI at 386 nm where ε1 was measured in 
10 mM TRIS buffer with 1mM EDTA and 50 mM NaCl and ε2 was 
measured in 2% SDS 
 
Compound ε1 ε2 
Mono-NDI 20,000 23,400 
Bis-NDI 27,000 44,000 
Tris-NDI 39,200 74,600 







Another approach to DNA immobilization on mica is to use 3-aminopropyletriethoxy 
silane (APTES) [93]. This method was briefly undertaken, but was found to be inferior 
due to its less uniform background surface deposition (Figure 3.5). Numerous other DNA 
immobilization techniques are dependent upon covalent bonding using chemical 
reactions with compounds such as thiols [94]. Concerns about interference with the drug 
binding under observation are greater under these conditions. 
 
Surface Immobilization 
Sample solutions were prepared in plastic microcentrifuge tubes with the following order 
of addition: filtered, deionized water, magnesium chloride/ammonium sulfate buffer, 
pRS316 DNA, and poly-NDI. Solutions were mixed using an Eppendorf micropipette 
and allowed to incubate at room conditions for thirty minutes to an hour to assure 
sufficient time for complete drug/DNA interactions to take place. Solutions were mixed 
using the pipette periodically throughout the incubation. Longer incubation times were 
used for the larger NDI molecules to provide extra time for interactions, especially based 
on the proposed threading mechanism. 
 
Half inch diameter disks of muscovite green mica (New York Mica Company, New 
York, NY) were freshly cleaved using transparent tape to peel off the top mica planes. 
Mica is a naturally occurring layered structure that easily forms atomically uniform 
planes. The surface is hydrophilic immediately after cleavage; however it can quickly 
become contaminated in the air and become hydrophobic. Therefore, all solutions were 







Figure 3.5 AFM topographical image of mica with 3-aminopropyltriethoxy silane 




Ten microliters of sample solution was pipetted into the center of the mica disk and 
allowed to incubate inside a humidity chamber for thirty minutes. The humidity chamber 
was constructed of a closed glass Petri dish with droplets of deionized water around the 
inside perimeter. The mica disks were placed on a Parafilm sheet in the center of the dish. 
This chamber was prepared at least 10 minutes prior to use to allow the humidity level to 
stabilize. The increased humidity helped reduce the rate of evaporation of the DNA 
solution on the mica to allow it to attach to the surface electrostatically, as opposed to 
being deposited during drying. A brief study was undertaken to confirm that both the 
initial DNA/drug incubation in solution and the application incubation on the mica were 
sufficient and did not change with increased time periods. 
 
Excess solution was wicked off the mica by touching the edge against a Kimwipe® wipe 
(Kimberly-Clark Corp., Dallas, TX). The sample was rinsed in 20 mL filtered, deionized 
water by dipping it perpendicular to the liquid surface three times. Previous studies also 
included an ethanol rinse to accelerate drying [95], however problems with ethanol 
contamination and concerns about converting some DNA from B form to A form resulted 
in the elimination of this step. The sample was thoroughly dried using a stream of 
nitrogen (~20 psi) at an approximately 60º angle to the sample surface. This process 
qualitatively seemed to improve the straightening of the DNA strands on the surface 
without putting them under too much stress.  
 
The use of centrifugal force to straighten the DNA molecules on the surface to facilitate 
length measurements was also explored. Yokota et al. [96] reported spin-stretching of 
 65
DNA by spinning at 4000 to 7000 rpm. This high force could result in elongation of the 
strands thus interfering with the detection of intercalation induced lengthening. A lower 
force was attempted by mounting the mica disk on a metal shim and attaching it to the 
center of a mini-centrifuge (VWR Scientific, Model V). Limited success was achieved in 
consistently applying the DNA and fear of potential damage to the centrifuge led to 
discontinuation of this approach. 
 
The mica was firmly attached to a 15 mm diameter metal shim (Ted Pella, Inc., Redding, 
CA) using an adhesive tab (Ted Pella). The metal shim served to mount the sample on the 
magnetic holder of the AFM piezo stack. It was critical to assure that the mica was well 
adhered to the surface to prevent movement of the sample during tapping mode imaging. 
 
Samples were stored inside a dessicator at room temperature to reduce hydration of the 
surface which could interfere with clear imaging of the DNA. However, complete 




The DNA lengthening assay can be fit to a theoretical model based on the McGee-von 
Hippel equation [97] which represents the binding affinity (Ka) as the quotient of the 
concentration of occupied intercalation sites and the concentration of unoccupied 


















































where Lo and L are the lengths of un-intercalated and intercalated DNA, D is the total 
DNA concentration, B is the number of basepairs per DNA, a is the lengthening per 
intercalation event, n is the exclusion number, and I is the total intercalator concentration 
[98]. This equation can also be solved for L to more easily be used in modeling (See 
Appendix B for derivation): 



















































The nearest neighbor exclusion number is based on the observed inability of ligands to 
intercalate between every basepair at saturation concentrations [99]. This limitation has 
been hypothesized to be due to steric hindrances [100]. In addition, with linked poly-
intercalators the rigidity and binding of the linker to the DNA may limit the availability 
of some sites. Iverson’s previous work with this series of NDI predicted a nearest 
neighbor exclusion number of 2 representing intercalation in between every other 
basepair [60]. A nearest neighbor exclusion number of 2 was also found for the related 
bisnaphthalimide LU-79553 based on NMR structural determination [66] (Figure 3.6). 
Additional research by Iverson’s group using an NDI series with a slightly different 
linker sequence of the same four amino acids showed a nearest neighbor exclusion 








Figure 3.6 Structural model of bisnaphthalimide LU-79553 with double-











       Source: www.cm.utexas.edu/Iverson/dnapolyi.htm 
 
 
Figure 3.7 NMR structure of related NDI compound (Gly-Gly-Gly-Lys) linker with a 
space of one open potential binding site between intercalating rings 
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Lengthening of the DNA molecule due to intercalation by a planar ring structure has 
generally been assumed to be equal to approximately its van der Waals thickness of 0.34 
nm [101]. This is also the distance between basepairs in B form DNA [37].  
 
Using the theoretical lengthening equation and assuming a nearest neighbor exclusion 
number of 2 and 0.34 nm lengthening per intercalation event, the expected lengthening of 
pRS316 versus bis-NDI concentration has been calculated (Figure 3.8).  
 
Contour Length Measurements 
The contour length of a DNA plasmid pBluescript II’ (provided by Nick Hud’s lab at the 
Georgia Institute of Technology) was measured for over one hundred strands and found 
to be 1155 + 85 nm (Figure 3.9). This agrees extremely well with the theoretical length of 
1163 nm for B-form DNA with 3421 basepairs. The pRS316 DNA was measured as a 
control for each set of NDI data and found to be 1660 + 118 nm. This also agrees 
extremely well with the theoretical length of 1662 nm for B-form DNA with 4887 
basepairs. A histogram of the strand length measurements is shown in Figure 3.10. The 
longer pRS316 DNA plasmid was chosen for future experiments. The balance of lower 
theoretical error with the difficulties finding well laid out strands for longer molecules 
needs to be considered. 
 
 A study of variances between researchers conducting the length measurements was less 
than 3%. Repeated measurements of the same strand yielded a variation between 0.5 and 














Figure 3.8 Theoretical lengthening of pRS316 assuming a nearest neighbor exclusion 
number (n) of 2, lengthening per intercalation (a) of 0.34 nm, and a 

































































Figure 3.9 Histogram of measured lengths of pBluescript II’ based on AFM images 
which correlate well with theoretical B-form length of 1.16 µm versus A-






























Figure 3.10 Histogram of measured lengths of pRS316 based on AFM images which 
correlate well with theoretical B-form length of 1.66 µm versus A-form 





Concentrations of bis-NDI were selected based on preparatory studies using the mono-
intercalator ethidium bromide which confirmed the ability to observe DNA lengthening  
using these experimental procedures. Bis-NDI concentrations of 10 µM, 25 µM, 36 µM, 
50 µM, 100 µM and 150 µM were prepared with a constant pRS316 concentration of 1 
µg/mL. The ratios of drug molecules to DNA basepair related to each of these 
concentrations are listed in Table 3.2. 
 
The average contour length increased with bis-NDI concentration (Table 3.2) confirming 
intercalation.  Similar findings based on UV-vis spectroscopy, viscometry, and DNAse 
footprinting have been reported [60]. Histograms of the length data indicate that although 
there were significant standard deviations, the lengths formed a reasonable distribution 
curve (Figure 3.11).  The data also reveals that the strands retained the B-form and did 
not form a mixture with A-form DNA. 
 
It should be noted that the DNA length actually decreased at a low concentration of 5 µM 
with a length of 1455 + 226. This is still greater than the expected length of A-form DNA 
(1271 nm). This apparent shrinkage of the DNA could be the result of kinking and 
bending of the DNA upon drug binding. DNA distortions have previously been described 










Table 3.2 Concentration-dependent lengthening of pRS316 plasmid with bis-NDI. 
Lengths at higher concentrations were Not Determined (ND) due to 












0 0 1660 118 
5 4 : 1 1455 226 
10 9 : 1 1893 177 
25 23 : 1 2114 333 
36 33 : 1 2150 99 
50 47 : 1 2193 417 
100 94 : 1 ND ND 
































































































































































Figure 3.11  Histograms of pRS316 length progressing with increasing bis-NDI 
concentration affirming retention of B-form conformation and lengthening 






DNA lengthening is expected to plateau as complete saturation of the intercalation sites is 
approached. However, at concentrations greater than 50 µM bis-NDI, secondary 
structures formed which did not permit accurate length measurement of single strands. 
More details about these secondary structures will be discussed in the following section. 
 
The measured lengths were matched to the theoretical model supposing a binding affinity 
of 4.0 x 104 M-1 and an exclusion number of 4 basepairs (Figure 3.12). The binding 
affinity is based on individual intercalation events and would be about 108 per bis-NDI 
molecule. This closely agrees with the binding affinity of  >107 estimated from DNAse 
footprinting studies [60]. The exclusion number of four corresponds to one un-
intercalated site between each linked intercalating NDI rings and one un-intercalated site 
between bis-NDI molecules.  
 
Bis-NDI Secondary Structures 
The studies not only measured DNA lengthening due to intercalations, they clearly 
identified conventional condensate structures of toroids, rods, and spheres, as well as the 
apparent intermediate structures of loops formed by increasing concentrations of  bis-
NDI. This was particularly interesting because while the compounds were anticipated to 
intercalate into the DNA, they were not expected to cause DNA condensation  
 
Interactions within single strands and between multiple strands to form complex 
secondary structures occurred progressively with higher bis-NDI concentrations (Figure 




































Figure 3.12 Plot of actual pRS316 lengthening with increasing bis-NDI concentration 
with corresponding theoretical curve calculating a nearest neighbor 
exclusion number (n) of 4 lengthening per intercalation (a) 0.34 nm, and a 





Figure 3.13 AFM intermittent contact image of pRS316 plasmid on mica under 
ambient conditions at increasing bis-NDI concentrations illustrating 
progression of secondary structures through condensation intermediates to 
fully formed condensed toroid and rod structures 
  10 µM bis-NDI 
  25 µM bis-NDI 
   100 µM bis-NDI 
  0 µM bis-NDI 
  150 µM bis-NDI 
   50 µM bis-NDI 
100 nm 100 nm 
40 nm 90 nm 
90 nm 80 nm 
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individual linear strands with only coincidental overlaps. At concentrations between 5 
and 10 µM, single and multiple loops began appearing within the strands. At 
concentrations between 25 and 50 µM clusters of loops that may be formed by multiple 
strands were observed, sometimes with clear foci at the intersection of several loops. 
Finally, at concentrations of 100 µM and higher, fully formed toroids, rods, and spheres 
were observed. Loose strands or loops radiated from many of the toroids and rods. A 
mixture of the structures were identified at the higher concentrations, as looped strands 
existed along with the completely condensed structures. 
 
The toroids, rods, and spheres are traditional condensate structures and potential 
intermediate structures that are similar to those observed by others [84, 85]. The initial 
phases follow an analogous pattern found by Berge using the bis-intercalator luzopeptin 
in MgCl2 buffer [82]. Yet Berge did not find complete condensate structures, probably 
because his studies used short (292 to 500 basepairs) DNA strands. It is necessary for 
DNA strands to be at least greater than 400 base pairs to form toroids [102]. 
 
DNAse footprinting results with this poly-NDI series had puzzling results at high poly-
NDI to DNA basepair ratios where all DNAse activity was suddenly lost [60]. These 
results now make sense in light of the condensation that appears to be occurring which 
would protect the DNA from ligation. The mono-intercalator did not have this effect 
(Figure 3.14). The DNAse footprints of the related poly-NDI compounds with a variety 








Figure 3.14 DNAse footprint where Cmpd. 1 is the mono-NDI, Cmpd 2 is the bis-
NDI, Cmpd. 3 is the tris-NDI, and Cmpd. 4 is the tetra-NDI. Note that no 
bands occur at the higher concentrations of bis-, tris-, and tetra-NDI 
indicating protection of the DNA strand from enzymatic activity as would 
be afforded by condensation [60]. 
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concentrations. Based on this, one can hypothesize that condensation is occurring with all 
of these molecules regardless of the position of the linker in the major or minor groove. 
 
The intermediate structures formed with bis-NDI were stable through the water rinsing 
and drying procedures, in contrast to those found by Hoh’s group using spermidine [84]. 
The effect of temperature during incubation of the drug with the DNA was examined 
with 50 µM bis-NDI at room temperature (25º C), body temperature (36º C), and elevated 
temperature (70º C). No change in morphology or distribution was found (Figure 3.15). 
 
Tris- and Tetra-Naphthalenetetracarboxylic Diimide 
Tris-NDI only had a limited effect on DNA lengthening (Table 3.3). It appeared that the 
plasmid lengths were slightly shortened, perhaps due to kinking and knotting of the 
strands. The formation of secondary structures begins at a low concentration of about 1 
µM, preventing measurement of individual strand lengths. 
 
Tetra-NDI also demonstrated slight concentration-dependent lengthening at extremely 
low drug concentrations (Table 3.4). The formation of secondary structures occurs at 
concentrations greater than 0.1 µM, again preventing measurement of individual strand 
lengths. Using the limited lengthening data and the direction provided by the bis-NDI 
model, the binding affinity was estimated to be 4 x 1012 with an exclusion number of 8 
basepairs for tetra-NDI.  This exclusion number is consistent with the bis-NDI pattern of 
one un-intercalated site between each linked intercalating NDI rings and one un-








Figure 3.15 AFM images of pRS316 with 50 µm bis-NDI at three incubation 
temperatures a) ambient (~25˚ C), b) body temperature (36˚ C), and c) 
elevated temperature (70˚ C) showing no significant difference in 











Table 3.3 Length measurements of pRS316 with increasing concentrations of tris-





Tris-NDI Compound : 





0 0 1660 118 
0.0014 1: 1000 1535 79 
0.014 1:100 1525 87 


















Table 3.4 Concentration-dependent lengthening of pRS316 plasmid with tetra-NDI 




Tetra-NDI Compound : 





0 0 1660 118 
0.0014 1: 1000 1735 69 





Tris-NDI and tetra-NDI followed the same morphology sequence as bis-NDI, but at 
much lower concentrations, even when corrected on a per intercalation unit (Figures 3.16 
and 3.17). This may indicate that cooperativity is occurring between the intercalation 
units of the molecule and perhaps between NDI molecules. At extremely low 
concentrations of tris- or tetra-NDI, linear strands could be found, but with a slight 
increase in concentration loops began to form. At slightly higher concentrations thick 
loops which looked like pre-toroids formed within strands, then rods, spheres, and toroids 
were identified (Figure 3.16). 
 
Thus, it has been determined using AFM that poly-NDI compounds interact with pRS316 
DNA and change its length and conformation. It has been conclusively demonstrated 
based on plasmid lengthening and bis- and tetra-NDI are intercalating with high binding 
affinities. Low concentrations of tris-NDI may also be intercalating, but the data was 
complicated by suspected strand deformations.  In addition, the unexpected ability of 
these poly-intercalators to cause DNA condensation was demonstrated.  
 
Discussion 
The condensation process is induced by poly-NDI intercalation. The role of Mg+2 in this 
process is unknown since the MgCl2 buffer concentration remained constant. Control 
samples with MgCl2 but without poly-NDI were devoid of DNA condensates. The MgCl2 
was required for immobilization of the DNA on the mica surface for AFM imaging. It has 




Figure 3.16 AFM intermittent contact image of pRS316 plasmid on mica under 
ambient conditions at increasing tris-NDI concentrations illustrating 
progression of secondary structures through condensation intermediates to 
fully formed condensed structures 
0.07 µM Tris-NDI
1 µM Tris-NDI
0.01 µM Tris-NDI 
10 µM Tris-NDI 




Figure 3.17 AFM intermittent contact image of pRS316 plasmid on mica under 
ambient conditions at increasing tetra-NDI concentrations illustrating 
progression of secondary structures through condensation intermediates to 






[103], leading to bending and stabilizing side-by-side association of DNA [104], 
conformational changes  [105], including major and minor groove binding and changing 
width [106]. It has been determined that divalent cations, such as Mg+2 cause aggregation 
at high concentrations (> 200 mM), but are not capable of DNA condensation on their 
own [107]. 
 
The lysine in the NDI linker provides a positive charge that may promote condensation. 
As mentioned in Chapter 2, condensation has been shown to occur with 90% 
neutralization of the anionic phosphate backbone. Because the poly-NDI molecule does 
did not have strong DNA sequence specificity, stable electrostatic interactions could not 
be formed at any sequence location. Therefore, the location of the lysine in relation to the 
DNA grooves cannot be specifically determined using NMR. 
 
A linker composed of the same amino acids in a different order with the lysine at the C-
terminus end of the tri-glycine had a substantial binding preference for a GC-rich 
palindrome sequence. NMR analysis of this molecule indicates that the lysine amine 
group extends from the major groove where it can interact with the anionic phosphate 
backbone [67]. A linker with tri-alanine substituted for the tri-glycine had a significantly 
different binding preference for an AT-rich palindrome sequence. NMR analysis of this 
molecule indicates that the linker binds in the minor groove, instead of the major groove, 
but again allows the lysine amine group to extend where it could interact with the anionic 
phosphate backbone [68].  
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The lengthening of the DNA at lower poly-NDI concentrations confirms that 
intercalation is occurring. The loops that are formed may be the result of intra- or inter-
strand intercalation or merely stabilization of interactions at the cross-over points. Loop 
formation has been hypothesized as the initial template for toroid formation [108]. 
 
Interaction Models 
Several models are proposed to describe the interaction of the poly-NDI molecules with 
DNA. The first set of models are based on sequential intercalation of all of the ring 
structures occurs (Figure 3.18). These models are generally consistent with the NMR 
images of the related poly-NDI compounds. As discussed above, the driving force for 
condensation in the model would primarily be based on the neutralization provided by the 
lysine. In addition, this model could rely on the bound intercalator to stabilize 
quadruplex-like structures that could arise in the condensate tertiary structures, as has 
been shown to be facilitated by other molecule/DNA complexes [109]. 
 
The second set of models require both mono-intercalation and groove binding of the 
second ring structure (Figure 3.19).This model infers that the binding affinity of poly-
NDI for the groove is comparable to that for intercalation. The binding affinity to the 
groove cannot be determined by AFM and is presently unknown. Models of only groove-
binding or non-classical interactions were eliminated based on the evidence of DNA 
lengthening which substantiates that some intercalation is occurring. A third set of 
models is based on intrastrand or interstrand cross-over binding (Figure 3.20). In these 
models one ring intercalates and the second ring either intercalates, groove-binds, or 
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otherwise binds to a remote area of the DNA. It can be envisioned how these models 
would account for loop formation that was observed in the secondary structures with 
lower poly-NDI concentrations believed to be condensate intermediates. It has been 
conjectured that loops may serve as a template for condensation [110]. Condensation 









Figure 3.18 Models of sequential intercalation of each ring moiety of the bis-, tris- and 
tetra-NDI molecules representing nearest neighbor exclusion numbers of 
4, 6, and 8, respectively where there is one open site between rings of the 






























Figure 3.19 Models involving groove-binding of the poly-NDI ring either exclusively 
(a) or in combination with intercalation (b). Lengthening measured with 
increased concentration of poly-NDI confirms that at least some 














Figure 3.20 Models of inter-strand or intra-strand intercalation (a) of ring moieties in 
which the rings from one poly-NDI molecule intercalate in remote areas of 
either the same DNA strand or of different DNA strands. Alternatively, 
one ring moiety may intercalate while the other may undergo groove 
binding (b). These models can be interpreted to facilitate loop formation 



















The toroid form is quite striking and the driving forces that lead to it, in preference to 
other geometries, are perplexing. Its spontaneous formation by DNA in vitro in the 
presence of condensing agents that mimic those found in vivo has facilitated studies into 
the energetics of DNA toroid formation. While toroids were first identified in 1972 by 
Evdokimov et. al  [111], a clear understanding of the mechanism of formation has yet to 
be determined. Over a hundred journal articles on DNA toroids have been published in 
the past five years. They are of key interest for applications in gene therapy delivery and 
antiviral treatments. 
 
Formation Driving Forces Theories 
There are several theories about the condensation process and its driving factors. One of 
the keys appears to be the stiffness of the DNA caused by the weak attractive force 
between DNA segments [69].  Some contend that condensation is due to electrostatic 
interactions which dominate entropy [112]. Others contend that hydration is the 
dominating attractive force responsible for condensation. The original Manning 
counterion condensation theory is based on the ratio of Bjerrum length to the charge 
separation distance being greater than one in order for condensation to occur [113]. This 
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is independent of counterion valency; therefore condensation must be more complex, as it 
has been shown the condensation is dependent on valency. The Debye-Huckel and 
Poisson-Boltzmann theories are not valid for DNA, especially with multivalent cations, 
because the Coulombic interactions are strong compared to the Boltzmann constant. The 
Poisson-Boltzmann theory would predict that the negatively charged DNA molecules 
should repel each other regardless of the charge of the neutralizing couterion [114]. 
Multivalency increases the magnitude of Coulombic interactions which allows it to 
overcome entropy for net attraction between like-charged ions. Manning later proposed 
that DNA bending occurs at this critical charge neutralization fraction which leads to the 
spontaneous formation of toroids [115]. A general notion exists that condensation takes 
place with 90% neutralization [103]. The correlated counterion fluctuation theory which 
accounts for attractive forces between the polyelectrolyte with same charge regions has a 
strong following and estimates greater counter ion adsorption than the Manning 
condensation model [116, 117]. 
 
Small angle neutron scattering experiments measured the partial structure factors of DNA 
and polyamine density correlations and determined that the polyamines are too large to 
penetrate into the grooves, which implies that their function in condensation is primarily 
electrostatic, rather than based on multivalent cation binding [118]. Based on NMR 
structures of related compounds, it has been hypothesized that the lysine which provides 
the positive amine charge to the poly-NDI structures is extending from the major groove 





The toroid structures that were formed by pRS316 linear plasmid DNA in the presence of 
high poly-naphthalenetetracarboxylic diimide (NDI) concentrations varied in size and 
shape (Figure 4.1). Many were oblong and several had “tails” or loops. The angle at 
which the toroid may be lying on the surface also distorts the shape. The variation is not 
unusual based on other published images of toroids analyzed with AFM [119, 120]. 
 
A true hole, as opposed to a cavity or indention, appears to be present based on sectional 
analysis of toroids with larger inner diameters (Figure 4.2). The height of the center of 
toroids with smaller inner diameters does not clearly show a return to surface level, but 
this is likely an artifact of the AFM’s ability to adjust to sudden changes in height or due 
to the orientation of the toroid on the surface 
 
Toroid Diameters 
Measurement of toroid outer and inner diameters was of interest to validate that the 
toroids formed with poly-NDI were similar to those formed with traditional condensing 
agents.  It could also be used to determine the toroid volume to help elucidate the number 
of DNA strands composing each toroid. 
 
Measurements of toroid diameters were performed using the Nanoscope software in the 
top view mode and section analysis mode (using half-height values) along the horizontal 




Figure 4.1 Portfolio of AFM images (400 nm scan sizes) of representative toroid 
structures formed by pRS316 and bis-NDI illustrating the diversity of 









Figure 4.2 Sectional analysis of toroid with half-height measurements of outer 







although the top view tended to be greater, as expected based on the use of half-height 
values for the sectional analysis. Half-height measurements are generally accepted as 
providing more accurate data by reducing the impact of tip geometry on measured 
widths; therefore, these measurements were used in these studies.  
 
The toroids formed with poly-NDI had measurements averaging 90 to 150 nm outer 
diameter and 25 to 45 nm inner diameter (Table 4.1) which matches that of toroids 
formed with traditional condensing agents such as spermidine [121], polylysine  [85], 
pegylated polymers [122], and others as measured by AFM and electron microscopy 
(EM) (Table 4.2). Dynamic light scattering (DLS) studies measured hydrodynamic radii 
of 40 to 60 nm for toroids in solution [70] [123] which has been interpreted to generally 
correspond well with the measurements similar to those obtained in our studies. Toroids 
formed with bis-NDI and tetra-NDI were similar in diameters. Very few clear individual 
toroids were identified with tris-NDI, although spheres and thick loops within strands 
were frequently formed with tris-NDI (Figure 3.16). 
 
The poly-NDI / pRS316 strand loops were found to be approximately 60 nm outer 
diameter which was about half of the diameter of the toroids and spheres. The radius of 
DNA loops in solution and the radius of toroids have been found to be similar [108]. This 
may support the notion that DNA loops that spontaneously form or are designed into the 
molecule serve as nucleation points for toroid formation [110].  
 







Table 4.1 Toroid dimensions as measured from sectional analysis of AFM images 













Bis-NDI (150 µM) 129 + 42 42 + 19 44 5.0 + 3.0 
Bis-NDI (100 µM) 146 + 44 36 + 19 55 5.1 + 1.0 
Tris-NDI* 58 + 14   4.2 + 1.7 
Tetra-NDI 91 + 11 28 + 8 32 2.2 + 1.1 
















Table 4.2 Dimensions of toroids formed with classical condensing agents collected 
from the literature. These measurements of diameter and height are in 

























[124] 82.8 + 9.7 9.6 + 1.6 protamine 7500 bp, 
linear 
AFM 
[125] 120 + 15 17 + 2 spermidine 48000 bp AFM 
[122] 133 + 23  pegylated 
polymer 
4365 bp and 
6000 bp 
AFM 
[24]  8 Ni II  AFM 
[126] 95 to 185 ~50 hexammine 
cobalt 
48000 bp TEM 
[127] 200  spermidine T4 (large) EM 
[108] 80 to 118  hexammine 
cobalt 
4500 bp TEM 
[114] 111.8 + 37.8  Ni II 800 bp AFM 











consideration. An increase of the apparent DNA strand width has been demonstrated to 
be dependent upon humidity [80].  Tip deconvolution was not conducted for the analysis 




As noted in chapter 1, AFM is known for its high resolution in the z-direction. The 
heights of toroids, loops, and strands were measured using the Nanoscope software 
sectional analysis tool. Toroids and rods had irregular heights and, therefore, were 
measured along the vertical, horizontal, and diagonal axes and averaged. Toroid heights 
with poly-NDI / pRS316 ranged from 0.7 to 15 nm, with a majority of the heights 
between 2 and 10 nm and a mean of 5 nm. This is in general agreement with previously 
published heights for toroids formed with traditional condensing agents such as spermine 
[120], polylysine [85], protamine [79], and others as measured by AFM (Table 4.2).  
 
It was surprising that the heights of the toroids were about an order of magnitude less 
than the width of the toroid ring which would lead to an interpretation of an oval cross-
section (Figure 4.3). Most studies using EM, which lacks the ability to determine z-range 
distances, have assumed that the toroids were of the classic mathematical torus structure 
with a circular cross-section, hence their name. It is known that AFM measurements of 
DNA strand heights are lower than the theoretical height of DNA. A recent study by 














may be embedded in a salt layer covering the mica surface which could account for part 
of the height difference, while the force exerted by the oscillating tip during imaging 




In order to determine if the force exerted by the AFM tip on the sample was compressing 
the toroids, a series of experiments were conducted using different imaging modes and 
cantilevers with different spring constants. Contact mode AFM was performed using a 
Sharp Microlever™ (model MSCT-A4FW) triangular cantilever at a range of setpoints 
from the minimum required to maintain contact to a force large enough to dislocate 
structures on the surface. The topographical images correspond to the increased force 
(Figure 4.4). However, the height of the toroid and rod, as measured with the sectional 
analysis, did not change with the exception of when they were reoriented on the mica 
surface (Table 4.3 and Figure 4.5). These results indicate that the condensate structures 
were either being compressed fully upon the initial setpoint or not compressed 
significantly even at the highest set point. 
 
The forces between the tip and the sample were calculated using Hooke’s law and the 
data from the AFM force curve using the following equation: 
 ( )ZkF ∆=  Equation 4.1
where F is the contact force, k is the cantilever spring constant, and ∆Z is the movement 





Figure 4.4 AFM contact mode images (800 nm scan size) of toroids and rod with 
increasing force exerted by tip on sample 
Setpoint –0.25 Setpoint –0.10 Setpoint 0.0 
Setpoint +0.20 Setpoint +0.40 Setpoint +0.80 











Table 4.3 Condensate structure height at increasing set points and corresponding 
calculated contact forces and pressures. Heights were determined as the 
average of three sectional analyses along the horizontal, vertical, and 















-0.25 24.3 -0.66 -0.21 2.98 2.63 
-0.10 24.7 -0.27 -0.08 2.92 2.65 
0.00 25.0 0.00 0.00 3.03 2.23 
0.20 25.5 0.53 0.17 2.94 ND 
0.40 26.0 1.06 0.33 2.97 2.56 
0.80 27.1 2.13 0.67 2.85 3.09 
1.00 27.6 2.66 0.84 2.87 3.59 
1.50 28.9 3.99 1.25 2.98 4.32 
3.00 32.9 7.97 2.51 4.50 ND 
 
ND= not determined 
Note: Underlined values denote that the structure was visibly reoriented on the mica 


























Figure 4.5 Plot of toroid height demonstrating no significant change with increasing 
contact force between the tip and sample using contact mode AFM 
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pull-off (rebound) point. The strong capillary forces of the hydration layer caused the 
rebound point to be outside the range of the detector; therefore, the retraction lines were  
extrapolated to determine the ∆Z value (Figure 4.6). The spring constant (k) of 0.03 N/m 
provided by the manufacturer was used for the calculations. The total force between the 
tip and the sample ranged from 24 nN to 33 nN (Table 4.3). However, a majority of this 
force can be attributed to the capillary force in which the water layer is pulling down on 
the cantilever, as opposed to force of the tip on the sample (Figure 4.7). A repulsive force 
of only a maximum of about 8 nN and a pressure of 2.5 megaPascals was obtained when 
the capillary force was deducted (Table 4.3). 
 
These are extremely low forces and would not be expected to compress the toroid. The 
theoretical pressure and force required to deform the toroid from a circular cross-section 









where ∆h is the deformation, h is the total height, E is Young’s modulus, and P is 
pressure. To estimate the deformation that would take place to compress a toroid with a 
width of 55 nm from a circular cross-section to an oval cross-section with a measured 
height of 5 nm, it would be assumed that the original total height would have been 55 nm. 
However, due to known tip artifacts that can broaden AFM width measurements, a 
conservative estimate of 45 nm was used. Another conservative assumption was made to 
use the Young’s modulus of a DNA strand (0.34 x 109 N/m2) [130] which would be 
expected to be significantly lower than that of the compact toroid structure. Based on 







Figure 4.6 Force curve from with contact mode experiment exported to a Microsoft 
Excel® spreadsheet and replotted using a macro developed by Mark Poggi. 
Retraction curve extrapolated to define rebound point. 
























∆ Z = 831 nm 
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Figure 4.7 Depiction of force curve with sample compression in the repulsive region 














































The estimated tip radius of curvature is 10 nm which would give a tip contact area of 
about 300 nm, resulting in a necessary compression force almost 100 nN. This is clearly 
several orders of magnitude greater than the repulsive forces calculated for the toroid 
imaging.  
 
The experiment was repeated under a nitrogen environment and the results were 
equivalent. In addition, a force volume experiment was attempted under nitrogen, but the 
capillary forces were greater than the deflection that would be associated with 
compressing a several nanometer sized structure. 
 
Tapping Mode 
The original toroid measurements were acquired using tapping mode which is the 
preferred mode for soft biomolecules due to its minimal force exerted on the sample. The 
actual force exerted by the tip on the sample was not calculated due to the complex nature 
of determining the cantilever mass and amount of dampening. Height and phase images 
were acquired at decreasing set points (related to increasing interaction forces) starting at 
the RMS value. The height images do not show any notable changes, while the phase 
images have reduced contrast with increased force, as would be anticipated due to higher 
forces reducing the amount of oscillation change (Figure 4.8). Again, the height of the 
toroid and rod did not change, as measured with the sectional analysis (Table 4.4 and 
Figure 4.9).  A brief tapping mode study using the Hi’Res probe (Figure 1.3c) at a 
minimal contact force due to the delicate nature of the tip also determined a similar toroid 
height (Figure 4.10). 
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Figure 4.8 AFM tapping mode height and phase images (600 nm scan size) obtained 
with a Nanoscope IIIa, Extended base, and J scanner with increasing tip 
interaction forces  
Height
Setpoint 0.70 V 
Setpoint 0.40 V
Setpoint 0.60 V 
Setpoint 0.50 V 












Table 4.4 Toroid, rod, and strand heights at decreasing set points (increasing 
interaction forces) as measured by sectional analysis of tapping mode 
topographical height images  
 
 Height (nm) 
Setpoint (V) Toroid 1 Toroid 2 Rod Strand 
1.15 2.11 ND ND ND 
1.12 2.09 ND ND ND 
1.00 2.07 ND ND ND 
0.90 2.09 ND ND ND 
0.80 2.00 ND ND ND 
0.70 2.09 1.81 3.14 0.42 
0.60 2.15 1.73 3.00 0.48 
0.50 1.95 1.78 3.08 0.42 
0.40 2.02 1.76 2.98 0.46 
0.30 1.99 ND ND ND 
































Figure 4.9 Plot of toroids, rod, and strand heights demonstrating no significant 
change with increasing contact force between the tip and sample using 









Figure 4.10 AFM tapping mode height and phase images of toroid using Hi’Res probe 
(slight multiple image due to small extratips) with sectional analysis 




Another key finding was that the repulsive regions of the force curves, both in contact 
and intermittent contact modes, had a slope of unity (Figure 4.11). This means that the 
movement of the scanner was proportional to the deflection of the cantilever which 
would not occur if compression or indentation were taking place (Figure 4.7).  
 
These determinations along with the fact that the condensate structures are highly 
compact and not expected to be easily compressible and are under 30 atmospheres of 
pressure within a viral capsid [131], support the conclusion that the height measurements 
are accurate and not significantly reduced by compression. 
 
The height of toroids induced with cobalt hexamine viewed from their edge has been 
shown with cryoelectron microscopy to have heights of approximately 50 nm [126]. This 
opens the question of whether the buffer-coated mica surface is involved in producing the 
oval cross-sectioned toroids seen in AFM samples in contrast to the toroids formed in 
solution for cryoEM. 
 
Toroid Volume 
The irregular dimensions of the toroids and rods made it unreasonable to calculate their 
volume or number of DNA strands per condensate structure. Some researchers have 
assumed a classical torus shape to calculate the volume, but we have shown that this is 
not valid based on the height and width differences. Others have used the packing 
fraction for hexagonal close packing of parallel cylinders [128], however, they also have 





Figure 4.11 Force curves at increasing setpoints (related to tip/sample force and 
pressure) that maintain a slope of unity in the repulsive regime 
Tapping Mode 
Setpoint = 0.7 V
Tapping Mode 
Setpoint = 0.3 V
Contact Mode
Setpoint = 0 V
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It has been proposed that multiple small DNA molecules or a single large DNA molecule 
form a single toroid because toroids seem to have similar outer and inner diameter 
distributions regardless of the DNA length [121]. The outer diameter remained fairly 
constant, while toroid height was influenced by λ-DNA (48 kb) concentration in AFM 
studies conducted by Lin et al. [125] using spermidine. They observed what they 
described as multimolecular toroids formed with DNA concentrations between 1 and 10 
ng/µL which had heights up to 60 nm (in increments of 11 nm), compared to 
monomolecular toroids with an average height of 17 + 2 nm that formed at lower DNA 
concentrations around 1 ng/µL. Accordingly, it has been suggested that most toroids only 
consist of single DNA molecules until higher concentrations provide pressures to force 
multiple strands together for toroid formation. 
 
Based on the literature summary (Table 4.2), it was noticed that there may be a 
relationship between the DNA length and the average toroid height (Figure 4.12), but 
there is insufficient evidence to draw a strong conclusion from this data because of the 
many other complicating variables involved in each of these experiments. 
 
Condensate Structure Distribution 
There is debate about the relationship between toroids and rods and the conditions that 
favor each morphology. The ratio of toroid to rod structures was found to increase from 
1:2.2 to 1:1.6 with bis-NDI concentration (Table 4.5). Rods seem to predominate with 
nonpolar solvents, such as ethanol [132], or condensing agents, such as permethylated 
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Figure 4.12 Relation of DNA plasmid length to toroid height (bars) and toroid outer 










Table 4.5 Distribution of condensation structures formed with bis-NDI at 100 µM 
and 150 µM concentrations. The quantity of well defined condensate 
structures increased with higher bis-NDI concentration, for example the 
number of toroids doubles. 
 
 
Structure 100 µM Bis-NDI 150 µM Bis-NDI 
Toroid 6% 12% 
Rod 13% 19% 
Coiled Strand 27% 29% 




exposed hetrocyclic bases [132]. Spherical globules, which were also observed with the 
poly-NDI, become predominate with increased cobalt hexamine concentration which has 
been attributed to greater compressive forces [134].  
 
The width of the poly-NDI toroids (outer radius to inner radius) averaged 55 to 32 nm 
and generally matched the width of the rods which averaged 34 and 31 nm formed with 
bis-NDI and tetra-NDI, respectively (Table 4.1). Other researchers also have found that 
the diameters and lengths of rods are similar to the thickness and circumference of toroids 
[135]. 
Condensation Process Theories 
Several theories exist about the toroid formation process. These will briefly be discussed 
in light of the data obtained with poly-NDI condensation of pRS316. 
 
A solenoid model has been proposed which purports that the DNA is wound like a string 
on a spool with the loops packed into a hexagonal lattice. Arguments against this model 
point out that crossover points between loops of different radii would have to be present 
[108]. Cryoelectron microscopy observations and modeling support regular hexagonal 
packing without crossover points [126]. 
 
A competing model has been proposed by Hud, et al. [108] which contends that DNA 
loops form a template for additional loops of DNA to accumulate to create a toroid 
structure. This has been supported by studies that demonstrated that the toroid size can be 
controlled by using DNA with engineered A-tract loops of varying diameters. 
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Other models have been proposed based on the potential relationship between toroids and 
rods in that the rod may bend around [136] or open up [86] to form a toroid. Arscott et al. 
have proposed that toroids are formed by circumferential winding of the DNA strand, 
while rods are formed by abrupt bending and kinking of the DNA strands [128]. 
 
AFM images acquired through these studies can be interpreted to support almost any of 
these theories depending on the viewpoint of the examiner; therefore, it does not seem 
practical to assign them as the basis for any particular model. There are images that show 
strands extending out of the toroids and rods (Figure 4.13a) which could imply a 
solenoid-like toroid formation model. There are images that show loops extending out of 
toroids and rods (Figure 4.13b) that could endorse the loop based formation models. 
Further, there are images with u-shaped and tennis racquet-shaped rods (Figure 4.13c) 
that could substantiate the rod bending models. 
 
One could speculate the following progression of events for condensation based on the 
results reported. First, the divalent cations in the buffer allow the DNA to become more 
flexible due to electrostatic shielding. Then, the first poly-NDI ring intercalates into the 
DNA and the lysine groups further charge neutralize the DNA phosphate backbone. The 
second poly-NDI ring could then intercalate to stabilize loop structures. With further 
charge neutralization from increasing poly-NDI concentrations, the loops may collapse 

















Figure 4.13 AFM images of condensation intermediates formed by pRS316 with poly-
NDI a) toroids and strands with radiating strands, b) toroids and strand 






COMMERCIAL APPLICATION AND VALUATION 
 
Program Introduction 
An assessment of commercial applications of this technology was made as a part of the 
TI:GER (Technological Innovation: Generating Economics Results) program. The 
TI:GER program was a joint program between the Georgia Institute of Technology and 
Emory University, funded by the National Science Foundation, and modeled after Purdue 
University’s Innovation Realization Lab. It was a multidisciplinary program that brought 
together Georgia Tech Ph.D. students in science and engineering, Georgia Tech M.B.A. 
students, and Emory University law students. This program aimed to bring together the 
different students to focus on the interface of technical, management, legal, and economic 
issues involved in taking fundamental research into the marketplace.  
 
The TI:GER program officially started in the Fall of 2002 with 21 members.  
The program was recognized for its leadership in teaching entrepreneurship. Founder Dr. 
Marie Thursby and program director Alan Flury accepted the Price Institute Innovative 
Entrepreneurship Educators Award in 2003 on behalf of the program.   
 
The central goal of program was to give student members a unique experience working 
first hand with the commercialization process for new technology.  The multidisciplinary 
teams worked together to resolve real commercialization and intellectual property issues 
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and developed the skills to advance early-stage research into real market and business 
opportunities.  
 
 The research reported herein, investigating the use of Atomic Force Microscopy (AFM) 
to study drug and DNA interactions, was one of the first Ph.D. research areas chosen 
suitable for TI:GER. A TI:GER team to determine the commercial suitability of the 
technology was formed during the first semester of the program. The team was composed 
of two Ph.D. students (Elizabeth Gadsby, Benay Sager), two M.B.A. students (James 
Hutchinson and Brandon Walts), and a J.D. student (Kankindi Rwego, then  Michael 
Kang).   
  
Technology Definition 
The technology was defined to be a novel application of the AFM for observing and 
analyzing the binding of compounds with DNA. AFM was demonstrated to allow direct 
imaging of DNA molecules and its interactions with drug compounds, including the 
binding location, twisting and kinking, and lengthening. The activity of the drug is often 
linked to the binding mode and resulting geometry. Thus, the potential activity of a drug 
could be assessed by detecting the DNA binding mode and fit of the drug candidate. By 
having specific knowledge about the interactions researchers could be better able to 






The DrugDock™ technology could be used to observe a broad variety of compounds 
interacting with DNA. The primary use that was proposed is a target validation tool for 
drug design. In addition, DrugDock™ could be used for drug screening through 
verification of the desired DNA-drug interactions. The method could also be applied to 
disease research to observe interactions of cellular compounds or viruses with DNA.  
Another possible application is in the field of environmental and ecological research 
investigating the effects of contaminants and other compounds on DNA. 
 
Intellectual Property 
The proposed technology to be known as DrugDock™ is an intangible process comprised 
mostly of a method for facilitating drug research, design, and screening. Intellectual 
property protection to support commercialization was studied. The TI:GER team 
explored the possibilities that the DrugDock™ method could be the subject of trade 
secret, patent, copyright, and trademark protection.   
 
A trade secret would require that the technology or commercially valuable information be 
kept confidential. Trade secret protection would not be suitable in this situation because 
of public policy and the disclosure necessary for drug development. The Georgia Institute 
of Technology, as a public institution, has a responsibility to make its research available 
for the benefit of the community according to the Bayh-Dole Act. This public policy 
coupled with the reality of the Food and Drug Administration’s stringent disclosure 
requirements for drug approval suggest that the method could only be used for its 
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intended purpose of drug development and design if the method and its results were 
publicly available.  
 
Patent protection gives an inventor or patent assignee the right to prevent others from 
using, making, or selling the invention. According to 35 U.S.C §101, a drug design 
research method, such as DrugDock™, is a process that is eligible for patent protection in 
the United States. The DrugDock™ method most likely surpasses the law’s minimal 
utility requirements. Patentability also depends on the novelty of the process. A 
patentability search was conducted in order to appraise the likelihood of patent 
protection. The results of patentability searches showed that the DrugDock™ technology 
has not been the subject of a patent. Broader searches surveying the landscape of AFM 
technology showed alternative uses of AFM. 
 
Although patent protection is stronger than trade secret protection, it is only for a limited 
time. Patents typically endure for a term of twenty years after the application date. A 
provisional application does not require claims or examination, is fairly inexpensive, and 
provides protection for up to twelve months (35 U.S.C. §111(b)(2002)). According to the 
American Intellectual Property Law Association, law firms charged a median of $2,501 
for provisional patent in 2000 [137].  During the twelve months of protection, 
DrugDock™ can be labeled “patent pending” thereby giving notice to others of the intent 
to file a patent application (35 U.S.C. §111(b)(2002)). An original non-provisional patent 
application on a relatively complex biotechnology or chemical invention has a median 
law firm price of $9,967. In addition, application amendment arguments for relatively 
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complex biotech/chemical patent applications have a median cost of $2,499. Considering 
that the PTO claims that a challenge-free patent application averages three years, 
applying for a patent in the United States alone is time consuming and expensive [137].  
 
Based on discussions with the Georgia Tech Office of Technology Licensing (OTL), an 
invention disclosure was prepared. Georgia Tech OTL decided not to apply for patent 
coverage. 
 
Copyright protection of original written documents is provided under 17 U.S.C.  §102(a) 
(2002). Instructional manuals and promotional materials and articles describing the 
benefits of DrugDock™ could be copyrighted. There are a variety of media which could 
engender sources of copyright including internet web sites, academic journals, and 
advertisements in industry publications.  
 
A trademark is a distinctive name that informs consumers of a single source for a 
product. It can be federally registered with the Patent and Trademark Office (PTO) under 
the U.S.C. §1051(Lanham Act§1)(b)(3)(2002). The TI:GER team brainstormed several 
potential names for the technology and selected the name DrugDock™ to represent the 
ability to investigate the “docking” of drugs into DNA and to provide a play on words of  
“doctor” since it is related to the pharmaceutical field. A search of the PTO database 
revealed that DrugDock™ was not registered, however DrugDoc, a mark for a 
bioinformatics software program, had been abandoned. The registration of the trademark 
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name DrugDock™ could distinguish this AFM method from other research tools and add 
reputation-related value to the technology.  
 
Target Market 
The primary market contemplated was pharmaceutical research and development (R&D). 
Pharmaceutical manufacturers, independent contract research laboratories, government 
research laboratories and academic research labs all perform R&D of new drug 
compounds for human use. Additionally, there are possible veterinary applications, 
though they are not typically as well-funded as drugs for human use. Other research 
applications might be in medical disease or environmental effects laboratories. 
 
The pharmaceutical market is huge, and growing. Worldwide sales of pharmaceutical 
products topped $400 billion in 2002, about a 9% increase over the previous year’s sales.  
To support this level of activity, $63 billion was spent on research and development. Of 
this amount, $2.5 billion was spent by the largest 18 companies on gene-related drugs 
(amounting to 5% of their total R&D expenditure) while $1.5 billion was spent on high-
throughput drug screening products, technologies and services [138]. As the rate of R&D 
expenditure rises and the rate of new drug approval falls, the pharmaceutical industry 



























Source: Amersham Biosciences Annual Report 2002, PhRMA 
 
Figure 5.1  Trends in worldwide R&D expenditure ($ billions) versus U.S. FDA new 
drug approvals 
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The rewards for the successful pharmaceutical manufacturer are huge, as well.  A drug is 
considered a “blockbuster” when its sales reach $1 billion per year, a level that 44 drugs 
sold in the United States had reached by 2000.  Such sales levels are needed with the 
average capitalized cost per marketed drug reaching an estimated $802 million over the 8 
to 12-year discovery and development process.  An estimated 7 of 10 drugs never sell 
enough to justify the investment in their development. 
 
Tufts University’s Center for the Study of Drug Design (CSDD) claims that 93.3% of 
284 new drugs approved in the U.S. in the decade 1990 to 1999 originated in industry 
labs, with 3.2% in government labs and 3.5% in academic and other non-profit labs. 
CSDD estimates that 30% of R&D monies are spent in the preclinical phase. The 
preclinical cost of bringing a new drug to market is estimated at $121 million of 
expenditure, which is equivalent to $335 million when the time value of money is 
considered, and is growing at 7.6% per year. For every 5,000 compounds considered, 
only five proceed to a clinical test phase, and only one reaches the market. 
 
 R&D executives are seeking ways to improve the efficiency of the discovery and 
development process, and pharmaceutical industry executives are emphasizing the 
development of drugs for chronic diseases to maximize the likely return on their 
investment. These trends are good news for DrugDock™ which is expected to lead to 
quicker, better-informed decisions in the drug discovery and screening process. 
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The market may be segmented in many different ways. One obvious way would be to 
divide the revenues into those produced by patented drugs and those whose patents have 
expired, usually known as generics. As may be expected, the profit margins are much 
wider for patented drugs than for the generics, as the producing companies try to pay for 
the considerable effort that is expended in bringing a new drug to market. DrugDock™ is 
expected to be of value in bringing new drugs to market, and, therefore, is not likely to be 
applicable to the generic market. Another segmentation method is to divide the market 
into prescription and over-the-counter (OTC) drugs. Since DrugDock™ is expected to be 
of value in a relatively new area of treatment, it is expected that the OTC market is not 
applicable in this analysis. Another way to segment the market would be by the action 
that the drug takes to defeat the targeted malady. There are numerous mechanisms and 
given that the mechanism of targeting DNA with drugs to prevent disease is expected to 
be particularly suited to the treatment of some of the most intractable problems in the 
medical world such as cancer, the potential is great. Sales of cancer treatment drugs 




The competition is considered to be the current methods of target validation, although the 
possibility of parallel development of a similar technology must not be discounted in this 
new and expanding field. Current methods utilize general analytical laboratory 
instruments such as NMR and X-ray crystallography to visualize DNA. Both of these 
methods have major drawbacks in that they require significant sample preparation, they 
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average the results of a large number of molecules, and data interpretation is much more 
challenging. 
 
X-ray crystallography requires a large sample of pure crystalline material that is difficult 
to obtain from larger molecules.  This limitation prevents the evaluation of the 
compounds in their natural state which would likely effect activity. NMR can be 
conducted in liquid state, similar to physiological conditions. However, NMR requires a 
moderately large sample size (millimolar range) which is difficult with relatively 
insoluble compounds. Long data collection times are necessary to overcome this 
sensitivity limit using a pulse sequence design. In addition, NMR has limited resolution, 
especially for larger molecules (greater than 25 kDa). 
 
Commercial Venture Options 
There were several business venture formats that were considered for the 
commercialization of the technology. First, the inventors could start their own company 
to test, design, and research clients’ drugs and/or compounds on a fee basis. Second, 
AFM manufacturers could license the method to make their product more salable to their 
current customer base and potentially widen the market for atomic force microscopes. 
Third, individual pharmaceutical firms could license the technology to characterize 
DNA-drug binding interactions while developing their product to provide a competitive 
advantage. Fourth, analytical service bureaus catering to the pharmaceutical industry 




It was considered that operating a laboratory requires significant start-up costs:  a 
substantial capital investment, expensive specialized labor, and possibly official 
certification to satisfy regulatory constraints. Laboratories already in the market offer a 
variety of services to the industry. A “one-trick pony” laboratory would not be likely to 
successfully compete in this environment, even with patent protection, unless the value 
added by the technology is exceptional. Therefore, the licensing business venture options 
are indicated. 
 
The technology product is entirely in the area of intellectual property in the combination 
and proper use of instruments and components produced by other parties. The AFM 
instrument used is purchased on the market and used unmodified, and the drugs and DNA 
used are similarly sourced externally.  A manual or other training materials would add 
value to the transfer of the technology. Possibly a limited amount of consulting or support 
services could also be arranged. Therefore, the operations that derive revenue from the 
DrugDock™ technology are associated almost entirely with the marketing of it. 
 
Marketing 
DrugDock™ is a quite specialized technology.  A broadcast marketing campaign is not 
necessary, and several suitable vehicles exist for alerting the community of possible 
users. The pharmaceutical industry has a number of journals, magazines, and 
organizations to serve it. Publication of the research results in one or more peer-reviewed 
journals will alert the community to the existence of the technology. An advertisement in 
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an industry magazine timed to coincide with research publication would reach an 
audience of the more business-related side of the industry, and would generate a second 
channel of demand pull as well as instigate intra-company conversation about the 
technology. Another channel for raising awareness of the availability of the technology is 
the Internet. A polished-looking, informative website is a must in the information age 
 
It is possible to contact a large portion of the target market of pharmaceutical R&D labs 
directly. A brochure extolling the benefits of DrugDock™ can be placed in the hands of 
decision-makers in this way.  The key companies are readily identified through the 
website of the Pharmaceutical Research and Manufacturers Association of America at 
www.phrma.org. Collaboration with AFM manufacturers (Table 1.1)  could be pursued 
as well. They may be in possession of customer lists outside of the pharmaceutical 
research industry who may nevertheless be interested in licensing DrugDock™ 
technology. An incentive to the AFM manufacturers for cooperation in this matter could 
be increased sales of their instruments to customers interested in the new application. 
 
Roadblocks and Risks 
Every new technology faces a variety of roadblocks or risks as it is developed toward 
marketability, and DrugDock™ is no exception. The risks considered are developmental 




Developmental risks are the risks encountered in proceeding from theory to practice. 
Every new technology faces unpredictable challenges in its development. The risks of 
failure or delay are higher when developing something completely new or when 
extending the limits of a technology than when developing procedures that are within the 
capability of a technology. The latter is the case for DrugDock™ for which the concept 
has been proven in the laboratory and the milestones for further development do not 
represent large technological leaps forward, but rather application of accepted laboratory 
practices to optimize the operation of the AFM. The valuable product that is the 
DrugDock™ technology is intellectual property, and the outlook for obtaining the 
necessary patent is good.   
 
Operational Risk 
Operational risks are the risks encountered in the production of the revenue-producing 
product. In general these might include risks from other segments of the value chain, 
risks from the acquisition and maintenance of plant and property, risks involved in and 
risks involved in manufacturing the product or providing the service, and risks in 
delivering the product or service to the customer. The operations risks for DrugDock™ 
are low. Such a concept of operations for commercialization leads to a high-fixed-cost 
business model, such as for software, music, or other products consisting primarily or 
solely of intellectual property. The marginal cost in producing more revenue by licensing 




Market risks are those involved in producing a customer perception of value in the 
product. Such risks might include the risk of technological obsolescence or the risk that a 
competitive product might be preferred, perhaps due to a different performance profile or 
lower price. While the ability to investigate the binding mode of compounds with DNA is 
expected to result in a benefit of reduced money and time spent in the preclinical R&D 
phase, the amount of this benefit is as yet un-quantified. The risk of not being sufficiently 
valued by customers to produce profits must be considered moderate. The risk of low 
demand can also be derived from other factors. For instance, growth in the DNA-targeted 
drug market may be low.  
 
Competitive Risk 
There is a competitive risk of parallel development of a substantially similar technology. 
The AFM instrument itself is fairly new, and further uses for it and achievements with it 
are regularly reported in the literature. Another competitive risk is the possibility that  the 
advantages afforded by AFM technology is not significantly valued above the current 
methods of NMR and X-ray crystallography, even with their drawbacks. Finally, there is 
some concern expressed in public forums regarding the enforcement of process patents. 
Even though the ability to draft a patent with broad protections might give a level of 
confidence that infringement is unlikely, the globally-distributed nature of the 
pharmaceutical industry, the proprietary nature of research laboratories and the uneven 





Many decisions made in the development of a technology are contingent on its potential 
value in the market, making valuation one of the earliest and most important tasks in the 
innovation process. Valuation drives or contributes information for decisions such as 
whether to devise a business strategy based on licensing or starting a venture business 
organization and the type of intellectual property (IP) protection to seek. Valuation 
entails understanding the “pain” in a market and how the technology might be of value in 
alleviating it. 
 
The value of DrugDock™ is not a single number. Rather, it is a range of values produced 
by different methods. Many assumptions go into any valuation, since it is an attempt to 
discover something that is unknown. This valuation contains more assumptions than 
most, produced as it was made with limited connections to the industry, dealt with an 
industry that does not share information about specific costs, and concerns a new 
technology which may be disruptive in nature. 
 
There were multiple challenges in attempting to value DrugDock™.  Foremost among 
them was the dearth of solid information available about the pharmaceutical R&D 
decision process. The difficulty of making decisions regarding which potential drug 
compounds to pursue was the subject of many publications in both the industry press and 
in academic journals. Many competing theories were promoted as providing the best 
support for making decisions in the face of tremendous uncertainty. In addition, the real 
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costs involved in R&D were not often shared by firms in this very competitive industry. 
Appearing either too proficient or too inefficient could attract attention from potential 
acquiring companies. Aggregate data was available from some academic sources and 
industry associations, but its applicability to any particular firm was questionable given 
the wide range of sizes and capabilities of firms in the industry.   
 
Net Present Value / Discounted Cash Flow  
This standard valuation method involves projecting a series of cash flows into the future 
for a reasonable number of periods, assuming a terminal value based upon a fixed growth 
rate, and discounting all the cash flows back to the initial period. Strengths of this method 
include its transparency and simplicity, but it is notoriously inflexible. Still, other 
methods like Adjusted Present Value, Expected Net Present Value (NPV), and real 
options analysis only add value when there are events that are likely to occur, and 
outcomes that are known to a reasonable probability. Such a level of detail is overkill for 
such an early-stage technology, the future of which is so nebulous.  
 
The keys to NPV analysis for DrugDock™ are in the choice of cash flow and growth 
rate, and to a lesser degree discount rate. The cost of capital will vary somewhat 
according to the firm, but a sensitivity analysis can show the range of possibilities. 
Continuing in reverse order, the growth rate may be assumed by assessing the industry’s 
desire for the product. Since the pharmaceutical R&D industry is actively seeking ways 
to improve efficiency and DrugDock™ offers just that, a relatively higher rate of growth 
may be assumed. Indication of the possibility of cash flow would flow from unit price 
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times units sold, but that analysis has not been done for DrugDock™.  A more general 
way would be to assess the time value savings that DrugDock™ might provide and 
estimate what proportion of that savings that might be charged for its use. 
 
The CSDD estimates that $121 million is spent per approved new drug in the preclinical 
phase, where DrugDock™ is expected to be of use. That money is spent winnowing five 
thousand candidates down to the five that will enter the clinical phases for each new drug 
to reach the market. Of course, some compounds are eliminated early in the process 
(estimated to take 52 months) and others later, but assuming the average yields $24,200 
per compound. Assuming the average compound makes it to the midway point, it is under 
consideration for 26 months, meaning that about $930 per compound per month is spent.  
Information from a pharmaceutical industry executive indicates that it takes from 
$100,000 to $300,000 per year to employ and equip a researcher (the so-called Full Time 
Equivalent, or FTE cost).  Again taking the average, and assuming a 50-week year, an 
FTE is $4,000 per month, so a researcher can handle about 4.3 compounds per month on 
average. If DrugDock™ can provide a 10% reduction in the time it takes to evaluate a 
compound, then an FTE could handle 4.8 compounds per month. The 52 months become 
46.8, and a savings of $12.19 million is realized without considering the time value of 
money back to the initial period. A 5% time savings similarly yields a $6.145 million 
savings by the time an investigational new drug reaches clinical testing. Assuming an 
average of 2 years to reach the savings and a 12% cost of capital those figures are $9.7 
million and $4.9 million, respectively. 
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Not every compound will be suitable for screening with DrugDock™, so assuming it will 
only be used to screen 10% of compound candidates, and 10% of the potential cost 
savings can be wrought from the industry, one percent of $49 million (to use the lower 
time savings estimate, times 10 per year) is $490,000 per year. 
 
Alternatively, the average of the two new cancer drugs Eloxatin and Faslodex, $75.6 
million and $23.6 million respectively, can be used to make another estimate.  Assuming 
the average level of sales of $49.6 million is reached in year 12 currently, the value of 
reaching the market 6 months earlier (reflecting a bit better than a 10% reduction in pre-
clinical discovery time) would be $24.8 million (6 months’ sales) divided by the factor of 
1.1211.5, or 3.6814.  This yields a value of $6.74 million. 
 
For the range of potential values ($490k, $674k, and $970k) of full market penetration, 
assume first year sales of 5%, then a series three years doubling sales each year, then a 
series of more moderate growth (20% annually) for four more years, then growth 
thereafter only with the economy. 
 
Comparable Analysis  
Many new technologies follow similar trajectories in their growth and adoption by the 
marketplace. The key is to choose as models technologies that are comparable in 
appropriate ways. DrugDock™ will compete in an interesting environment. The 
techniques currently used to image DNA and to evaluate binding of compounds to DNA 
are general laboratory techniques performed with more-or-less general laboratory 
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instruments, some of which are much more expensive than a $120,000 AFM, some of 
which are much less. The capital expenditure will be acceptable to the largest labs, but as 
with other expensive and perhaps specialized technologies, DrugDock™ is expected to 
be attractive to service bureaus that can invest in the equipment and then take in a 
sufficient volume of work from many smaller labs, those that lack the requirement for 
full-time access to such technology, in order to make the investment pay off. 
 
Identifying a comparable technology is difficult, and finding sales and use information is 
more so. The existence of an industry selling market reports for nearly $4,000 a copy is 
an indicator of the magnitude of the task. However, a quite comparable technology that is 
popular enough to appear in some detail in the industry press is Polymerase Chain 
Reaction (PCR). PCR does not accomplish the same task as DrugDock™, however, it is 
sold to a similar market and it has exhibited a strong intellectual property protection plan 
from the start which has created value for its developers. 
 
PCR was invented in the 1980’s in California by Nobel Prize winner Kary Mullis and 
developed by Cetus Corporation. The process involved repeated heating of a solution 
containing a particular enzyme that promoted the reproduction of copies of subject DNA. 
The process and the solution were patented, and Cetus licensed to Perkin Elmer the 
production of an instrument designed to perform the cyclic heating of the solution. From 
1987 to 1990, the sales of the thermocycler increased at a CAGR of 123.5%. Cetus 
received approximately 15% of sales from Perkin Elmer as payment. Cetus then sold the 
rights to PCR in 1991 to Hoffmann-La Roche, which continued the license arrangement 
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with Perkin Elmer, which collected a $10,000 license fee with the sale of each 
thermocycler. In addition, Hoffmann-La Roche sold kits containing the solution with the 
enzyme and licensed production of the solution in return for a 15% royalty. By 1997 the 
total business in the PCR technology was reported at $300 million annually, which 
represents a CAGR of 41.63%. 
 
Certainly the continued success of PCR is remarkable, and it is not reasonable to assume 
such success for DrugDock™. PCR is much more widely applicable, producing as it does 
the raw material for other DNA lab work, while DrugDock™ is a tool for analysis.  PCR 
is widely used in research labs and in diagnostic work as well. We could use PCR as a 
model by assuming only a tiny fraction of its sales, one tenth of one percent, and 
assuming a conservative growth rate. 
 
Venture Capital Analysis  
Venture capitalists (VC) are in a risk-laden business. They follow a portfolio approach in 
attempting to reduce risk to the minimum by diversifying their investments in the nearly-
sure knowledge that some of the companies in which they invest funds will provide no 
return. The hope is that through judicious choice of the teams and technologies one or 
more of the young businesses will succeed handsomely, with a many-fold payback of the 
investment at the end of the time horizon. To this end, VC’s use a harsh discount rate.   
 
Beginning with an estimate of the worth of the firm at the end of the investment horizon, 
they calculate NPV using discount rates in the neighborhood of 50%. This will normally 
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produce a valuation much lower than the other methods, which is a reflection of the risk 
being undertaken by the investors. A range of discount rates, from 45% to 60%, and a 
range of future values based upon different growth rate assumptions from a very low 
growth rate of 2% to a supernormal growth rate of 8% was used to produce a matrix of 
possible values. The projected required return rate was adjusted upward to account for the 
higher expectation of risk. A net cash flow assumption of 15% of the sales expected in 5 
years was used.  Assuming the middle value from the DCF cash flow analysis of 
$674,000 and using a recent average 5-year risk-free rate, about 5%, to project about 
$820,000 in sales.  Net cash flow of 15% is roughly $123,000 per year. 
 
Using various methods, DrugDock™ is estimated to have a value between $69,000 and 
$5.4 million at its current, early stage of development, depending the estimation of risk 
and on the forecasts for growth of sales, the market and the economy.  These numbers 
indicate that Georgia Tech’s Office of Technology Licensing should seriously pursue 






Many new questions have arisen and paths to pursue discovered based on the novel 
findings of the research reported herein. A few of the key suggestions are outlined for the 
consideration of future researchers. They focus on gaining a better understanding of the 
DNA/drug interaction and DNA condensation process by exploring the impact of the 
DNA length and sequence, the role of the polyintercalator linker, and the influence of the 
preparation conditions. Experiments to test some of the hypotheses set forth in this 
dissertation are also proposed. 
 
DNA Length and Sequence 
The studies in this dissertation focused on the pRS316 linearized DNA plasmid with a 
length of 4,887 basepairs. This plasmid was selected based on its length being 
sufficiently long enough to allow significant lengthening with intercalation to increase 
the signal to noise ratio, yet short enough to allow some of the strands to lie on the 
surface with minimal crossovers. Because DNA with short lengths, less than 400 bp, are 
not able to form condensate structures [102], they would be useful for observing bending 
in a manner similar to that done by Berge et al. with luzopeptin [82]. Experiments with 
short linear DNA strands could help elucidate if intermolecular interactions are occurring 
as suggested in the model in Figure 3.20.  
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It was noted from the literature survey summary in Table 4.2 and Figure 4.12 that there 
appears to be a potential link between the DNA plasmid size and the thickness of the 
toroid as measured by AFM. However, there were numerous other complicating variables 
in these studies. For that reason, it would be worthwhile to conduct a controlled study 
observing toroids formed by various lengths of similar DNA sequences with a uniform 
drug to DNA basepair concentration. 
 
Additionally, it would provide insight to observe the interactions of the poly-NDI with 
DNA molecules composed of different GC to AT ratios which may lead to condensation 
at lower concentrations or at different ratios of toroid to rod structures. DNA containing 
specific sequences such as A-tracts may also impact condensation. A-tracts were used by 
Hud’s group to cause curvature to produce static loops in the DNA and theoretically 
serve as templates for toroid formation [108]. 
 
It would be interesting to explore the effect of poly-NDI on chromatin condensation 
compared to naked DNA. Chromatin is the nucleoprotein complex of DNA with histone 
proteins and related proteins found in higher order cells. Sen and Crothers studied the 
impact of magnesium ions and bis-intercalators with a 3+ charge on chromatin 
condensation [139]. It would be revealing to determine if the lesser charged poly-NDI 





DNA Binding Ligands 
Other suggestions for future research are directed toward variations of the DNA binding 
compound, such as modifications of the polyintercalator compound or compounds with 
different binding modes. Investigation of the ability of other related poly-NDI 
compounds created from the combinatorial library [62] would allow analysis of the role 
of the linker sequence. It has been proposed that the lysine in the linker is responsible for 
charge neutralization of the DNA backbone resulting in its condensation. This concept 
would generally by supported by the ability to produce similar condensation reactions 
with other poly-NDI compounds containing a lysine or other positively charged amino 
acid in the linker. The impact of the location of the lysine or positively charged amino 
acid in the linker would help further in the understanding of the role of the linker 
sequence. 
 
The poly-NDI molecules studied in this research were found not to be sequence specific, 
but other related poly-NDI molecules were sequence specific which allowed their 
structure to be resolved using NMR.  Specifically, a poly-NDI with a linker sequence of 
Gly-Gly-Gly-Lys has been shown to have the linker bind in the major groove [67], versus 
the compound with a linker sequence of Ala-Ala-Ala-Lys that the linker binds in the 
minor groove [68]. A comparison of these two compounds may reveal the effect of the 
linker position relative to the DNA grooves.  
 
The rigidity of the linker likely has an important impact on the mode of DNA 
interactions. It is anticipated that a very rigid linker that positions the intercalator 
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moieties in parallel would help differentiate between the sequential intercalation model 
(Figure 3.18) and the intrastrand intercalation model (Figure 4.20). The rigidity of the 
linker may also affect the ability of the DNA/ligand complex to bend and form 
condensate structures. 
 
Exploration of other poly-intercalators and their linker structure would expand the 
understanding of the role of intercalation in condensation. Initial studies were conducted 
using the mono-intercalator, ethidium bromide (EtBr), and the bis-intercalator, ethidium 
homodimer (EtDi) (Figure 6.1). Lengthening was observed with the ethidum bromide 
which confirmed intercalation, but no significant secondary structures arose with 
increasing EtBr concentration (Figure 6.2). The preliminary data revealed greater looping 
structures and a few small condensate intermediate-like structures at higher ethidium 
homodimer concentrations (Figure 6.3). A molecule with a single ethidium ring and the 
linker is being synthesized in Bottomley’s lab following the procedure outlined by 
Benson et al. [140]. A comparison of the effects of the single ethidium with the linker 
with the mono-intercalator and the bis-intercalator will be evidence for the role of the 
linker in forming secondary structures.  A further comparison could be made with the 
commercially available heterodimer of ethidium and acridine intercalators with the same 
linker structure. 
 
A similar study with the mono-intercalator of NDI and the mono-NDI with the Lys-Gly-
Gly-Gly linker would help differentiate between the role of the intercalating ring moiety 








Figure 6.1 Chemical structure of ethidium homodimer-- a bis-intercalator composed 
of one of the most commonly used intercalators, ethidium, linked by a 
polyamine similar to spermine, a classical condensing agent 
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Figure 6.2 Representative AFM image of pRS316 with 1.0 µM ethidium bromide on 
mica illustrating strand lengthening due to intercalation, but no significant 






Figure 6.3 AFM images of pRS316 with 0.1 and 0.15 µM  ethidium homodimer  on 
mica showing secondary structure formation  
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involvement of multiple intercalation points on distant regions of the same or different 
DNA strands to form loop structures or stabilize multi-strand condensates (Figure 3.20). 
It is expected that the mono-NDI alone would not lead to DNA condensation based on its 
DNAse footprint (Figure 3.14). 
 
Experiments using compounds known to utilize other DNA binding modes such as 
groove binding with high concentrations and similar charge intensities could indicate the 
function of intercalation versus charge neutralization in causing condensation. 
  
Influence of Cations 
Magnesium chloride (MgCl) was used in the buffer to generate electrostatic binding of 
the DNA to the mica surface during sample preparation in the studies reported in this 
dissertation. It is recognized that the magnesium ion may have an influence on the DNA 
conformation and the interactions between the poly-NDI and the DNA. Controls were run 
that confirmed that the buffer alone did not change the secondary structure of the DNA. 
Others’ experiments have also determined that divalent cations, such as Mg+2, are unable 
to induce DNA condensation [107]. 
 
However, these cations may facilitate condensation based on their ability to increase 
DNA flexibility, bending, and conformational changes [103-105]. Specifically, 
magnesium cations have been shown to have an effect on the size of toroids based on 
research with hexamine cobalt as the condensing agent [71]. Studies to probe the function 
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of the MgCl should include the use of other monovalent and divalent cations in the 
preparation buffer at various levels. 
 
Intermediate Condensation Structures 
Interesting secondary structures, described as loops and flowers were imaged in addition 
to the completely formed condensate structures of toroids, rods, and spheres.  The 
progression of the formation of these structures was consistent for the bis-, tris-, and 
tetra-NDI molecules in relation to their increase in concentration. Recurrence of this 
pattern in the studies proposed above with various DNA sequences, different poly-
intercalators or other DNA binding ligands would provide strong support that these are 
intermediate structures in the condensation pathway.   
 
Ultimately, this work and expansion upon it may lead to a better understanding of DNA 
condensation which can be applied to gene delivery systems and anti-viral agents. It may 
also help direct the development of better drugs based on the insight of poly-intercalators 
interactions with DNA. 
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APPENDIX A:  pRS316 DNA SEQUENCE 
 
bp #
1 T C G C G C G T T T C G G T G A T G A C G G T G A A A A C C T C T G A C A C A T G C A G C T C C C G
51 G A G A C G G T C A C A G C T T G T C T G T A A G C G G A T G C C G G G A G C A G A C A A G C C C G
101 T C A G G G C G C G T C A G C G G G T G T T G G C G G G T G T C G G G G C T G G C T T A A C T A T G
151 C G G C A T C A G A G C A G A T T G T A C T G A G A G T G C A C C A C G C T T T T C A A T T C A A T
201 T C A T C A T T T T T T T T T T A T T C T T T T T T T T G A T T T C G G T T T C T T T G A A A T T T
251 T T T T G A T T C G G T A A T C T C C G A A C A G A A G G A A G A A C G A A G G A A G G A G C A C A
301 G A C T T A G A T T G G T A T A T A T A C G C A T A T G T A G T G T T G A A G A A A C A T G A A A T
351 T G C C C A G T A T T C T T A A C C C A A C T G C A C A G A A C A A A A A C C T G C A G G A A A C G
401 A A G A T A A A T C A T G T C G A A A G C T A C A T A T A A G G A A C G T G C T G C T A C T C A T C
451 C T A G T C C T G T T G C T G C C A A G C T A T T T A A T A T C A T G C A C G A A A A G C A A A C A
501 A A C T T G T G T G C T T C A T T G G A T G T T C G T A C C A C C A A G G A A T T A C T G G A G T T
551 A G T T G A A G C A T T A G G T C C C A A A A T T T G T T T A C T A A A A A C A C A T G T G G A T A
601 T C T T G A C T G A T T T T T C C A T G G A G G G C A C A G T T A A G C C G C T A A A G G C A T T A
651 T C C G C C A A G T A C A A T T T T T T A C T C T T C G A A G A C A G A A A A T T T G C T G A C A T
701 T G G T A A T A C A G T C A A A T T G C A G T A C T C T G C G G G T G T A T A C A G A A T A G C A G
751 A A T G G G C A G A C A T T A C G A A T G C A C A C G G T G T G G T G G G C C C A G G T A T T G T T
801 A G C G G T T T G A A G C A G G C G G C A G A A G A A G T A A C A A A G G A A C C T A G A G G C C T
851 T T T G A T G T T A G C A G A A T T G T C A T G C A A G G G C T C C C T A T C T A C T G G A G A A T
901 A T A C T A A G G G T A C T G T T G A C A T T G C G A A G A G C G A C A A A G A T T T T G T T A T C
951 G G C T T T A T T G C T C A A A G A G A C A T G G G T G G A A G A G A T G A A G G T T A C G A T T G
1001 G T T G A T T A T G A C A C C C G G T G T G G G T T T A G A T G A C A A G G G A G A C G C A T T G G
1051 G T C A A C A G T A T A G A A C C G T G G A T G A T G T G G T C T C T A C A G G A T C T G A C A T T
1101 A T T A T T G T T G G A A G A G G A C T A T T T G C A A A G G G A A G G G A T G C T A A G G T A G A
1151 G G G T G A A C G T T A C A G A A A A G C A G G C T G G G A A G C A T A T T T G A G A A G A T G C G
1201 G C C A G C A A A A C T A A A A A A C T G T A T T A T A A G T A A A T G C A T G T A T A C T A A A C
1251 T C A C A A A T T A G A G C T T C A A T T T A A T T A T A T C A G T T A T T A C C C T G C G G T G T
1301 G A A A T A C C G C A C A G A T G C G T A A G G A G A A A A T A C C G C A T C A G G A A A T T G T A
1351 A A C G T T A A T A T T T T G T T A A A A T T C G C G T T A A A T T T T T G T T A A A T C A G C T C
1401 A T T T T T T A A C C A A T A G G C C G A A A T C G G C A A A A T C C C T T A T A A A T C A A A A G
1451 A A T A G A C C G A G A T A G G G T T G A G T G T T G T T C C A G T T T G G A A C A A G A G T C C A
1501 C T A T T A A A G A A C G T G G A C T C C A A C G T C A A A G G G C G A A A A A C C G T C T A T C A
1551 G G G C G A T G G C C C A C T A C G T G A A C C A T C A C C C T A A T C A A G T T T T T T G G G G T
1601 C G A G G T G C C G T A A A G C A C T A A A T C G G A A C C C T A A A G G G A G C C C C C G A T T T
1651 A G A G C T T G A C G G G G A A A G C C G G C G A A C G T G G C G A G A A A G G A A G G G A A G A A
1701 A G C G A A A G G A G C G G G C G C T A G G G C G C T G G C A A G T G T A G C G G T C A C G C T G C
1751 G C G T A A C C A C C A C A C C C G C C G C G C T T A A T G C G C C G C T A C A G G G C G C G T C G





1851 G G C C T C T T C G C T A T T A C G C C A G C T G G C G A A G G G G G G A T G T G C T G C A A G G C
1901 G A T T A A G T T G G G T A A C G C C A G G G T T T T C C C A G T C A C G A C G T T G T A A A A C G
1951 A C G G C C A G T G A A T T G T A A T A C G A C T C A C T A T A G G G C G A A T T G G A G C T C C A
2001 C C G C G G T G G C G G C C G C T C T A G A A C T A G T G G A T C C C C C G G G C T G C A G G A A T
2051 T C G A T A T C A A G C T T A T C G A T A C C G T C G A C C T C G A G G G G G G G C C C G G T A C C
2101 C A G C T T T T G T T C C C T T T A G T G A G G G T T A A T T C C G A G C T T G G C G T A A T C A T
2151 G G T C A T A G C T G T T T C C T G T G T G A A A T T G T T A T C C G C T C A C A A T T C C A C A C
2201 A A C A T A G G A G C C G G A A G C A T A A A G T G T A A A G C C T G G G G T G C C T A A T G A G T
2251 G A G G T A A C T C A C A T T A A T T G C G T T G C G C T C A C T G C C C G C T T T C C A G T C G G
2301 G A A A C C T G T C G T G C C A G C T G C A T T A A T G A A T C G G C C A A C G C G C G G G G A G A
2351 G G C G G T T T G C G T A T T G G G C G C T C T T C C G C T T C C T C G C T C A C T G A C T C G C T
2401 G C G C T C G G T C G T T C G G C T G C G G C G A G C G G T A T C A G C T C A C T C A A A G G C G G
2451 T A A T A C G G T T A T C C A C A G A A T C A G G G G A T A A C G C A G G A A A G A A C A T G T G A
2501 G C A A A A G G C C A G C A A A A G G C C A G G A A C C G T A A A A A G G C C G C G T T G C T G G C
2551 G T T T T T C C A T A G G C T C G G C C C C C C T G A C G A G C A T C A C A A A A A T C G A C G C T
2601 C A A G T C A G A G G T G G C G A A A C C C G A C A G G A C T A T A A A G A T A C C A G G C G T T C
2651 C C C C C T G G A A G C T C C C T C G T G C G C T C T C C T G T T C C G A C C C T G C C G C T T A C
2701 C G G A T A C C T G T C C G C C T T T C T C C C T T C G G G A A G C G T G G C G C T T T C T C A A T
2751 G C T C A C G C T G T A G G T A T C T C A G T T C G G T G T A G G T C G T T C G C T C C A A G C T G
2801 G G C T G T G T G C A C G A A C C C C C C G T T C A G C C C G A C C G C T G C G C C T T A T C C G G
2851 T A A C T A T C G T C T T G A G T C C A A C C C G G T A A G A C A C G A C T T A T C G C C A C T G G
2901 C A G C A G C C A C T G G T A A C A G G A T T A G C A G A G C G A G G T A T G T A G G C G G T G C T
2951 A C A G A G T T C T T G A A G T G G T G G C C T A A C T A C G G C T A C A C T A G A A G G A C A G T
3001 A T T T G G T A T C T G C G C T C T G C T G A A G C C A G T T A C C T T C G G A A A A A G A G T T G
3051 G T A G C T C T T G A T C C G G C A A A C A A A C C A C C G C T G G T A G C G G T G G T T T T T T T
3101 G T T T G C A A G C A G C A G A T T A C G C G C A G A A A A A A A G G A T C T C A A G A A G A T C C
3151 T T T G A T C T T T T C T A C G G G G T C T G A C G C T C A G T G G A A C G A A A A C T C A C G T T
3201 A A G G G A T T T T G G T C A T G A G A T T A T C A A A A A G G A T C T T C A C C T A G A T C C T T
3251 T T A A A T T A A A A A T G A A G T T T T A A A T C A A T C T A A A G T A T A T A T G A G T A A A C
3301 T T G G T C T G A C A G T T A C C A A T G C T T A A T C A G T G A G G C A C C T A T C T C A G C G A
3351 T C T G T C T A T T T C G T T C A T C C A T A G T T G C C T G A C T G C C C G T C G T G T A G A T A
3401 A C T A C G A T A C G G G A G G G C T T A C C A T C T G G C C C C A G T G C T G C A A T G A T A C C
3451 G C G A G A C C C A C G C T C A C C G G C T C C A G A T T T A T C A G C A A T A A A C C A G C C A G
3501 C C G G A A G G G C C G A G C G C A G A A G T G G T C C T G C A A C T T T A T C C G C C T C C A T C
3551 C A G T C T A T T A A T T G T T G C C G G G A A G C T A G A G T A A G T A G T T C G C C A G T T A A
3601 T A G T T T G C G C A A C G T T G T T G C C A T T G C T A C A G G C A T C G T G G T G T C A C G C T








3701 G T T A C A T G A T C C C C C A T G T T G T G A A A A A A A G C G G T T A G C T C C T T C G G T C C
3751 T C C G A T C G T T G T C A G A A G T A A G T T G G C C G C A G T G T T A T C A C T C A T G G T T A
3801 T G G C A G C A C T G C A T A A T T C T C T T A C T G T C A T G C C A T C C G T A A G A T G C T T T
3851 T C T G T G A C T G G T G A G T A C T C A A C C A A G T C A T T C T G A G A A T A G T G T A T G C G
3901 G C G A C C G A G T T G C T C T T G C C C G G C G T C A A T A C G G G A T A A T A C C G C G C C A C
3951 A T A G C A G A A C T T T A A A A G T G C T C A T C A T T G G A A A A C G T T C T T C G G G G C G A
4001 A A A C T C T C A A G G A T C T T A C C G C T G T T G A G A T C C A G T T C G A T G T A A C C C A C
4051 T C G T G C A C C C A A C T G A T C T T C A G C A T C T T T T A C T T T C A C C A G C G T T T C T G
4101 G G T G A G C A A A A A C A G G A A G G C A A A A T G C C G C A A A A A A G G G A A T A A G G G C G
4151 A C A C G G A A A T G T T G A A T A C T C A T A C T C T T C C T T T T T C A A T A T T A T T G A A G
4201 C A T T T A T C A G G G T T A T T G T C T C A T G A G C G G A T A C A T A T T T G A A T G T A T T T
4251 A G A A A A A T A A A C A A A T A G G G G T T C C G C G C A C A T T T C C C C G A A A A G T G C C A
4301 C C T G G G T C C T T T T C A T C A C G T G C T A T A A A A A T A A T T A T A A T T T A A A T T T T
4351 T T A A T A T A A A T A T A T A A A T T A A A A A T A G A A A G T A A A A A A A G A A A T T A A A G
4401 A A A A A A T A G T T T T T G T T T T C C G A A G A T G T A A A A G A C T C T A G G G G G A T C G C
4451 C A A C A A A T A C T A C C T T T T A T C T T G C T C T T C C T G C T C T C A G G T A T T A A T G C
4501 C G A A T T G T T T C A T C T T G T C T G T G T A G A A G A C C A C A C A C G A A A A T C C T G T G
4551 A T T T T A C A T T T T A C T T A T C G T T A A T C G A A T G T A T A T C T A T T T A A T C T G C T
4601 T T T C T T G T C T A A T A A A T A T A T A T G T A A A G T A C G C T T T T T G T T G A A A T T T T
4651 T T A A A C C T T T G T T T A T T T T T T T T T C T T C A T T C C G T A A C T C T T C T A C C T T C 
4701 T T T A T T T A C T T T C T A A A A T C C A A A T A C A A A A C A T A A A A A T A A A T A A A C A C
4751 A G A G T A A A T T C C C A A A T T A T T C C A T C A T T A A A A G A T A C G A G G C G C G T G T A
4801 A G T T A C A G G C A A G C G A T C C G T C C T A A G A A A C C A T T A T T A T C A T G A C A T T A
4851 A C C T A T A A A A A T A G G C G T A T C A C G A G G C C C T T T C G T C  
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Definition of terms (units) 
K = Binding affinity (M-1) 
Lo = Length of un-intercalated DNA (nm) 
L = Length of intercalated DNA (nm) 
D = DNA concentration- total (M) 
B = Basepairs per DNA (bp) 
a = Lengthening per intercalation event (nm) 
n = Exclusion number (bp) 
I = Intercalator concentration- total (M) 
 
 
 [occupied intercalation sites] 
K =  ------------------------------------------------------          




• Define concentrations with known variables 
 








 −  
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KBIx +−−=  
 










 +−= 2  
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